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Abstract
The advanced modalities of radiotherapy like the Volumetric Modulated Arc Therapy (VMAT)
use non-uniform intensity fields allowing complex dose distribution patterns. The intensity mod-
ulation is obtained through the motion of the beam modifiers and, in concrete, in the case of the
VMAT therapy through the synchronized motion between the Multileaf Collimator (MLC) motion
and the Gantry rotation. The introduction of continuous motion with continuous treatment de-
livery introduces uncertainties and pose difficulties in the dose distribution calculation by Treat-
ment Planning Systems (TPS). In order to deal with the uncertainties introduced a dedicated
Quality Assurance (QA) program and patient-specific dose verifications are requested which
besides capturing the staff to perform the QAs it also consumes a precious time that could be
used in effective treatment. A viable alternative as a recognized golden standard for dose cal-
culation given its most detailed description of radiation-matter interaction could be through the
use of Monte Carlo (MC) methods. The caveats to this method are the not trivial set-up of the
RT model and treatment and also the time needed for execute the calculation. These caveats
have prevented the routinely use in clinic of this method, but recently, the PRIMO software was
proposed, providing several built-in RT units models, including TrueBeam, and with a user in-
terface that facilitates this work. Nevertheless, VMAT is not implemented yet and the core of
this work is about the feasibility of using PRIMO for advanced dynamic MC simulations.
With this purpose, a TrueBeam was simulated in PRIMO using 6 and 10MeV in Flatness Filter
Free mode and at 15MeV with Flatness Filter. The results were validated by Gamma Function
(2%, 2mm) based on reference measurements in water tank.
Since PRIMO can deal with multiple static fields, following a Position Probability Sampling
(PPS), the dynamic treatment delivery is divided into a customizable number of probabilisti-
cally sampled static configurations of jaws, leaves and gantry angles. In-house algorithms
were developed to interpolate the LINAC geometrical information along the procedure once the
planned information is retrieved from the DICOM plan file. A graphical user interface (GUI) was
developed to assist non-expert users to configure PRIMO to simulate complex deliveries.
Static simulations in reference conditions showed always > 97% of Gamma points < 1 for PDD
and profiles at various depths and fields sizes for the 6, 10 and 15MeV primary beam respec-
tively. The GUI properly read, manipulated and wrote the configuration data in a .ppj format,
which was accepted by PRIMO. The MLC model was validated against gafchromic measure
for the 6 and 10 MeV energies in FFF mode. The GUI successfully automatized the needed
tasks like the TPS treatment plan import, the dynamic treatment sampling, the primo file config-
uration, the several PRIMO output dose files integration and the export of the result in DICOM
ii
format.
Several tests were made to validate the sampling algorithm and the suggested workflow to
implement the VMAT simulation with the aid of PRIMO. The results obtained from gamma com-
parisons gave reliable outcome and great expectations for future work.
Keywords: FFF; PPS; VMAT; IMRT, MC; Dynamic, Motion; Radiotherapy; Sampling;
Algorithm; Advanced treatment; Matlab; PRIMO; PENELOPE
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Resumo
As modalidades avanc¸adas de tratamento radioterapeˆutico, como e´ exemplo a te´cnica volumet-
ric modulated arc therapy (VMAT), utilizam modulac¸a˜o na˜o uniforme de intensidade, permitindo
assim a construc¸a˜o de padro˜es complexos de distribuic¸o˜es de dose. A modulac¸a˜o de inten-
sidade e´ conseguida a` custa do movimento dos elementos modificadores de feixe e, no caso
concreto da terapia VMAT, atrave´s da sincronizac¸a˜o entre o movimento do multileaf collima-
tor (MLC) e o movimento da Gantry. A introduc¸a˜o do movimento contı´nuo sem interrupc¸a˜o
do tratamento introduz incertezas no processo e coloca dificuldades no ca´lculo por parte do
treatment planning system (TPS). De modo a controlar o processo um programa dedicado de
Controlo de Qualidade (QA) para verificac¸a˜o de dose e´ efetuado para todos os tratamentos e
pacientes, procedimento que ale´m de cativar recursos humanos para a sua realizac¸a˜o retira
tempo de disponibilidade ao Linac, tempo esse que poderia ser utilizado para tratamento efe-
tivo. Uma alternativa via´vel, reconhecida como standard para calculo de dose, dada descric¸a˜o
detalhada de interac¸a˜o radiac¸a˜o-mate´ria pode ser conseguida atrave´s da utilizac¸a˜o do Me´todo
e de Monte Carlo. Algumas dificuldade na utilizac¸a˜o deste me´todo sa˜o a complexidade na
configurac¸a˜o do modelo da unidade de RT bem como do plano de tratamento e o elevado
tempo normalmente necessa´rio para a realizac¸a˜o do ca´lculo. Estas dificuldades teˆm con-
tribuı´do para limitar a sua utilizac¸a˜o na rotina clinica, no entanto, recentemente, o software
PRIMO foi sugerido para ultrapassar estas limitac¸o˜es uma vez que tem pre´-definidos va´rios
modelos de unidades de RT, incluindo o TrueBeam, e expo˜e uma interface gra´fica e funcionali-
dades que facilitam este trabalho. No entanto o tratamento VMAT na˜o esta´ ainda implementado
e e´ precisamente a determinac¸a˜o da exequibilidade de utilizar o PRIMO para simular tratamen-
tos dinaˆmicos avanc¸ados em MC que constitui o nu´cleo deste trabalho.
Com este propo´sito foi simulada uma unidade TrueBeam em PRIMO, usando as energias de 6
e 10 MeV sem filtro aplanador e energia 15MeV com filtro. Os resultados obtidos da simulac¸a˜o
foram validados com a func¸a˜o Gamma (2%, 2 mm) tendo por refereˆncia as medidas em tanque
de a´gua do comissionamento da unidade.
O software PRIMO permite calcular a dose de va´rios campos esta´ticos, daı´ que para simular o
tratamento dinaˆmico, seguindo a abordagem Position Probability Sampling (PPS), o tratamento
e´ dividido num nu´mero customizado de configurac¸o˜es esta´ticas obtidas por amostragem prob-
abilı´stica da posic¸a˜o das jaws, das folhas do MLC e do aˆngulo da Gantry. Foram desenvolvidos
algoritmos proprieta´rios para interpolar a informac¸a˜o geome´trica do LINAC durante o processo,
a partir da informac¸a˜o extraı´da do ficheiro DICOM do planeamento.
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Foi tambe´m desenvolvida uma aplicac¸a˜o com interface gra´fica (GUI) para auxiliar um uti-
lizador gene´rico a configurar o PRIMO para realizar tratamentos complexos.
Simulac¸o˜es esta´ticas realizadas em condic¸o˜es de refereˆncia mostraram sempre > 97% de
pontos gamma < 1 quer para PDD quer para os perfis laterais, isto para va´rias profundidades
e tamanhos de campo e energias 6, 10 e 15 MeV. A GUI permite manipular e escrever os da-
dos de configurac¸a˜o no formato .ppj, formato esse aceite pelo PRIMO. O modelo do colimador
MLC foi validado tendo por refereˆncia medic¸o˜es com gafchromic para as energias de 6 e 10
MeV. A aplicac¸a˜o GUI automatiza va´rias tarefas necessa´rias, tais como, importar o ficheiro de
plano do tratamento, amostrar o tratamento dinaˆmico, configurar o ficheiro .ppp do PRIMO para
a simulac¸a˜o, integrar os va´rios ficheiro de dose e exportar os resultados em formato DICOM.
Foram realizados va´rios testes para validar o algoritmo de amostragem e para validar o work-
flow desenhado para implementar a simulac¸a˜o VMAT com recurso ao PRIMO. Os resultados
obtidos nas comparac¸o˜es gamma deixam antever expectativa favora´vel para a realizac¸a˜o de
trabalhos futuros.
Palavras-chave: FFF; PPS; VMAT; IMRT, MC; Dynamic, Motion; Radiotherapy; Sam-
pling; Algorithm; Advanced treatment; Matlab; PRIMO; PENELOPE
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1. Introduction
1.1 Motivation
In External Radiotherapy (RT), the idea of modulating the radiation field through a collima-
tion system motion developed into the Intensity Modulated Radiation Therapy (IMRT) concept.
IMRT is an advanced RT technique, which makes use of collimation system movement to mod-
ulate the radiation field in intensity. IMRT allows creating complex dose delivered distributions
patterns, at the price of great complexity, to achieve practical clinical gain. Arc Radiotherapy
(ART) is an extension of the IMRT technique, which introduces the rotation of he gantry dy-
namically during the treatment. In Medical Physics, several dosimetric problems have been
approached by means of the Monte Carlo (MC) simulation method [1]. MC approach is consid-
ered [2][3] as the golden standard method for dose calculation. In some cases it is the only one
to perform absorbed dose calculations because it provides the most detailed and complete de-
scription of the radiation fields and of the particle transport in tissues. Several codes have been
available for simulation in the field of RT, such as GEANT4, EGSnrc/BEAMnrc, PENELOPE,
FLUKA and MCNP. Recently, PRIMO, a new software simulation system that makes use of the
PENELOPE features, was developed [4]. This software has a user-friendly approach, which is
a suitable and competitive characteristic for clinical activity. Nevertheless, advanced features
such as IMRT/ART are not yet introduced.
Among the different LINAC models provided in the actual PRIMO release, Varian FakeBeam
is an available model of the Varian TrueBeam unit. TrueBeam has very peculiar features such
as the possibility of work in Flatness Filter Free (FFF) mode, respiratory gating and a real-time
tracking system. TrueBeam can be used for a wide range of RT applications, including stereo-
tactic and ART techniques. A version of PRIMO is installed at Instituto Portugueˆs de Oncologia
(IPO-PORTO), where previous experience on radiation beam modelling has been developed.
Different attempts have been made to simulate IMRT/ART treatment with different approaches.
The most common techniques are Static Component Simulation (SCS) [5] and the Position
Probability Sampling (PPS)[6].
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Since a Varian TrueBeam unit was installed in IPO-Porto and some tests of Monte Carlo (MC)
of dynamic treatments with PRIMO were also already made in-house, the conditions were set
for the development of this thesis.
1.2 Objectives
This thesis pretends to accomplish the following objectives:
• To create a fully detailed and validate model of the Varian TrueBeam unit
• To perform a feasibility study of VMAT simulation with PRIMO
• To optimize the algorithm to drive the PRIMO to simulate dynamical rotational procedures
• To assist the Medical Physics Department of the IPO in evaluating the quality of treatment
delivery
• To perform some treatment plans simulations for specific case with the aim of implement-
ing the procedure in the clinical activity.
1.3 Thesis Outline
This thesis is divided in 5 major chapters. Starting by this one where the theme is introduce
and the objectives delineated. Chapter 2 provides the theoretical background, approaching
the physics of radiation, the Linacs, advanced treatment techniques, Monte Carlo method and
principal codes used in radiotherapy, and the methods for dynamic treatment sampling. In
chapter 3 is described the implementation, with the materials used and the method followed.
Chapter 4 shows the results and in chapter 5 the final conclusions are drawn.
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2. Background
2.1 Radiotherapy Physics and dosimetry
2.1.1 Interaction of charged particle with matter
Charged particles incident on matter undergo inelastic and elastic interactions with atomic elec-
trons and nuclei, that is, other charged entities. Inelastic interactions include collisional and
radiative process and results in energy loss by the particle. In an elastic interaction the particle
is scattered by an atomic electron or nucleus, resulting in a change of direction for the particle
but no energy loss. The interaction probability for charged particles is effectively 1; an incident
charged particle interact at every opportunity.
Light Charged Particle Interaction: Electrons
The electron mass is small compared with any atomic mass, and incident electrons undergo
four types of particle interactions with a large amount of scattering, Figure 2.1. Collisional type
interactions result in energy loss, causing ionization or excited states (higher electron orbits).
The collisional losses increase as the electron velocity decreases, and decrease as the ab-
sorber atomic number increases. Radiative type interactions result in x-ray emissions. The
incident electron penetrates the electron cloud and interacts with the nucleus positive electrical
field, undergoing abrupt deceleration with energy loss and a change in direction. The energy
is released in the form of x-rays, called bremsstrahlung (or braking) radiation. With an incident
mono energetic electron fluency, a continuous x-ray spectrum is emitted because the proba-
bility of any energy loss, large or small, is equal per interaction. Successive bremsstrahlung
interactions may occur as the electron loses its energy; a bremsstrahlung x-ray spectrum has
a maximum energy equal to the initial electron energy and all other x-ray energies below this
maximum to zero. The radiative interactions are important as they are the mechanism by
which bremsstrahlung x-rays are produced in diagnostic x-ray tubes and linear accelerators.
Bremsstrahlung production increase at higher incident electron energies and higher Z of the
absorber.
4 FCUP
Clinical implementation of Monte Carlo simulations of a TrueBeam unit
Fig. 2.1. Electron interactions. A, Excitation. B, Ionization of outer shell. C, Ionization of inner shell. D,
Bremsstrahlung production.
2.1.2 Interaction of photons with matter
Photons are considered indirectly ionizing radiation, neutral particles which interact with the
medium following a two steps process:
i energy transfer to charged particles in medium and.
ii energy deposition in the medium by the resulting released charged particle.
In medical imaging and treatment of diseases (radiotherapy), high-energy photons, suchX-rays
and γ-rays, are commonly used. When a photon passes through some medium, three different
results may occur: the photon does not interact with the material; the interaction happens and
the photon is totally absorbed by the medium or the photon interacts depositing some of its
energy but its original trajectory is changed. The probability of occurring photon interactions
with matter depends on the photon energy, density of the medium and its atomic number.
Cross section
The interaction of photons with matter is a stochastic phenomenon and the probability of each
event to occur is driven by the cross section. The cross section is the parameter used to
express the probability of interaction for photon radiation. It is important to point out that, as
the interactions are stochastic phenomena, the particles in a photon beam, do not undergo the
same interaction with the matter as the type and parameters of the interactions follow specific
probabilities density functions. When considering the interactions of photons in an atomic scale,
the cross section is generally defined as the atomic cross section and it can be related to the
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effective area for an interaction between an X-ray photon and an atom of a particular material.
In general, the probability of occurrence of interactions depends both on photon energy and
atomic number of the medium. For the energy range applied in radiotherapy, the interactions
that show the highest probability to occur are the photoelectric absorption effect, incoherent
(Compton) scattering, pair production and coherent (Rayleigh) scattering, Figure 2.2.
Fig. 2.2. Relative importance of photon interactions as a function of photon energy.
However, among this, only the first three interactions lead to energy deposition, as they
result in the transfer of energy to electrons which will then impart it to matter in small Coulomb-
force interactions along their tracks. The Rayleigh scattering, being an elastic interaction where
the photon looses almost no energy and only the direction of the incident photons changes is
a process that do not contribute to the transfer of energy to the medium. Figure 2.3 illustrates
a scheme of these four processes.
Photoelectric absorption
The photoelectric effect is the predominant mode of interaction for photons of low energy, in the
energy range of several eV to around 0.1 MeV. In this process, the incident photon interacts
with a tightly bound electron (inner shells as K, L, M or N) and it is completely absorbed in
the interaction and the electron (named photoelectron) is ejected from the atom In order for
the photoelectric effect to occur, the incident photon energy has to be higher than the binding
energy of the electron. Thus, part of the photon energy is used to overcome the binding energy
and free the electron from the atom and the residual energy is transferred to the kinetic energy
of the escaping electron. As result of the emission of the electron, the atom is left in an excited
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Fig. 2.3. Schematic diagrams of the main interaction processes of the photons with matter: Rayleigh
scattering, Photoelectric effect, Compton scattering and Pair production.
state with a vacancy in the ionized shell. This vacancy can be quickly filled through the capture
of an outer orbital electron and, therefore, one or more characteristicX-ray photons (fluorescent
photons) may also be generated. In some fraction of the cases, the emission of Auger electrons
may substitute for the characteristic X-ray in carrying away the atomic excitation energy. The
probability of occurrence of the photoelectric effect varies roughly whit the energy of the incident
photon and the atomic number Z of the medium, the photoelectric effect will be enhanced
for photons of relatively low energy and for materials of high atomic number Z. The angular
distribution of the emitted electrons depends on the energy of the incident photon. For low
photon energy, the electrons are predominantly ejected at 90◦ relative to the photon direction.
With increasing the photon energy, the electrons are emitted in more forward directions [7].
Incoherent (Compton) scattering
In this case the photon interacts with a free electron or with an electron which binding energy is
negligible with respect to the incident photon. In this interaction the electron receives a fraction
of the photon energy and moves to a certain direction, while the photon is scattered in another
direction. This effect is predominant in low Z medium (e.g. human body) and at the usual
energies used in radiotherapy (from the order of magnitude of some MeV).
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Pair production
If the photon has energy larger than 1.02 MeV and passes near the nucleus it can interact
with its electric field and the result is the disappearance of the photon and the production of an
electron-positron pair. These two particles will move in opposite directions and each will carry
a kinetic energy of 0.511 MeV. The positron, the antiparticle of an electron, slows down quickly
and annihilates with a free electron giving off two 0.511 MeV photons that travel in opposite
directions. The probability of this interaction increases with Z2.
Coherent (Rayleigh) scattering
This interaction is purely elastic and of less importance for radiotherapy since there is no local
energy transfer, only scattering of the incident photon.
2.1.3 Photon attenuation coefficients
As it passes through the material, photons may undergo one or more interactions with the
atoms of the medium and some of them are absorbed or scattered leading to their removal
from the initial beam. The information about the passage of the photon beam through the bulk
material is given by the linear and mass attenuation coefficients. Both the primary and the
scattered photons are contained in the information provided by these coefficients.
Total attenuation coefficient
As the photon beam goes through the material its attenuation is a result from the effect of all
possible interaction processes and the total attenuation coefficient is expressed as the sum of
the individual coefficients.
2.1.4 Fundamentals of radiation dosimetry
The result of the interaction of the radiation with matter is the transfer of a certain amount
of energy to the matter through the processes of ionization and excitation. Based on this
consideration, there are many different quantities and units commonly used to describe and
quantify this energy transfer. An important basis for these concepts was provided in the 60’s and
70’s by the International Commission on Radiological Units and Measurements (ICRU). The
ICRU has developed and recommended a set of fundamental quantities and units in dosimetry
which has been in wide use for decades and has been vital to the successful exchange of
information, and comparison of results.
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Quantities and units
Generally, radiation fields are specified with two classes of radiometric quantities referring either
to the number of particles or to the energy transported by these particles. These are widely
used in practical applications of ionizing radiation as they provide a complete description of the
field.
Fluence and energy fluency
The particle fluence Φ gives the number of particles dN that cross a sphere of unit cross-
sectional dA:
Φ =
dN
dA
which is usually expressed in units of cm−2.
The energy fluence Ψ, which is a measure of the total amount of energy entering or leaving
a small volume, is defined as
Ψ =
dR
dA
where dR denotes the radiant energy incident on a spherical volume of cross-sectional area
dA. The unit for energy fluence is J m−2. By radiant energy R it means the energy (excluding
rest energy) of the particles emitted, transferred or received by all the particles striking the
spherical volume.
Kerma
The Kerma (K) quantity, acronym for Kinetic energy released per unit mass, is defined as the
total initial kinetic energy of the charged particles released by uncharged particles and can be
written as:
K =
dEtr
dm
in which dEtr is the expectation value of the energy transferred to the charged particles
in a finite volume V at a point P and dm is the mass of the volume V where the energy was
transferred. The unit for kerma is the same as for dose, that is, the Gray (Gy) with 1 Gy = 1 J/kg.
As this charged particle can loose their energy through collision or by radiative interaction, the
Kerma is usually separated into two components:
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k = Kc +Kr
where Kc and Kr refer to the collision and radiative interactions, respectively.
Charged particle equilibrium
Charged particle equilibrium (CPE) is an important concept in external dosimetry, especially for
photon radiation, since it allows establishing the relations between certain basic quantities. The
basis of the CPE is the existence of an energy balance in a volume that will exist if each charged
particle of a given type, energy and direction leaving the volume is replaced by an identical
particle of the same type and energy entering the volume. One important consequence of the
CPE conditions is the equivalence of the absorbed dose and the kerma. In general, the transfer
of energy (kerma) from a photon beam to charged particles at a particular location does not
lead to the absorption of energy by the medium (absorbed dose) at the same location, basically
due to the finite range of the secondary electrons released by photon interactions but in CPE
conditions it is possible to relate absorbed dose usually to collisional kerma Kc as mentioned
before. Generally, in more realistic situations CPE is not usually achieved and there are two
clear instances where CPE is not expected to be achieved:
1. in the build-up region of a beam where the dose increases rapidly until electronic equi-
librium is achieved at the depth dm of maximum dose. Beyond dm, photon attenuation
results in transient electronic equilibrium (i.e., energy in is slightly greater than energy
out) and a decrease in dose with depth ;
2. near the edges of a finite beam at distances between the beam edge and the point under
consideration larger than the maximum secondary electron range (penumbra region).
Absorbed dose
The absorbed dose D is probably the key quantity in respect to the clinical effects of the ra-
diation interaction with matter. This concept is relevant to all types of ionizing radiation fields,
either directly ionizing, such as electrons, either indirectly ionizing, such as photons. According
the ICRU Report (1980), absorbed dose is defined as the mean energy imparted d by the
ionizing radiation to the absorbing material of mass dm:
D =
d
dm
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The unit for dose is the Gray (Gy).
The energy included in this definition is the energy actually transferred from the radiation, inde-
pendently of its type, i.e., whereas the concept of kerma deals only with primary interactions in
matter, absorbed dose deals with all the interactions taking place in the medium.
It is known that the absorption of energy does not take place at the same location as the trans-
fer of energy described by the kerma. However, both quantities are related to each other when
conditions of charged particle equilibrium (CPE) exist at the point of dose calculation, that is,
when the charge entering a volume is equal to the charge leaving the same volume for each
type of particle and for each energy, and under this conditions:
D
CPE
= Kc
Exposure
Exposure, X, is defined by the ICRU as the quotient of the absolute value of the total charge of
the ions of one sign produced in air (dQ) by the mass of air where all the electrons produced
by photons are completely stopped (dm) , that is,
X =
dQ
dm
The SI unit for exposure is Ckg−1.
Several important concepts characterize exposure, X:
1. It is defined for all ionizations, primary and secondary, when produced and measured in
air.
2. It is defined only for ionizing photons (x- and γ rays), not electrons or other particles.
3. It is properly measured only under conditions of electronic equilibrium, and it is difficult to
measure for photon energies higher than 3 MeV. Above this energy the electron t range
in air becomes too large for electronic equilibrium to be achieved practically.
2.1.5 General considerations of basic dosimetry
Generally, radiation dosimetry can be divided into two different procedures, namely absolute
and relative dosimetry. Whereas the absolute dosimetry is based on the dose measured at
a given point, in the relative dosimetry the dose measured at a point of interest under certain
irradiation conditions is compared to the measured dose value obtained at a reference point
under specific reference conditions. All the information provided either by ionization chamber or
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other dosimeter may allow the performance of a 3D-characterization of the dose distribution for
each type of radiation, material and setup. Clinically, the characterization is usually performed
through Percentage Depth Dose (PDD) and transversal dose profiles. The first type of profiles
are defined as the quotient, expressed as percentage, of the absorbed dose at any depth d
to the absorbed dose at a fixed reference depth d0, along the axis of the beam (usually, Z
axis). For photon beams, the typical reference depth is taken at the position of the maximum
dose, denoted as dmax. For radiotherapy beams, Percentage Depth Dose (PDD) are usually
calculated or measured for a given field size and at a predetermined source surface distance
(SSD). Typically, tables of percentage depth dose data for clinical use are provided for a variety
of field sizes at a standard SSD of 100 cm.Transversal dose profiles are determined across
the given field (usually, X or Y axis) at a specified depth. This type of profiles is important
to determine the appropriate field size of a radiation beam and to ensure thus an adequate
dosimetric coverage of the tumor. In addition to these profiles, it is also usual to obtain a 2D
distribution of the dose at a given depth or location. This 2D diagrams are usually known as
isodose lines maps, which gives a scheme of the points or zones in a medium that receive
equal doses of radiation.
2.2 The Medical Linear Accelerator (LINAC)
For the majority of cancer treatments, radiotherapy is recommended at some stage. The Linear
electron accelerator (LINAC) is by far the most common equipment used for this delivery. Here
is presented a general description of the common design principles of a typical modern LINAC,
remarking that some differences exists between vendors.
2.2.1 Unit composition
By heating of a tungsten filament (the electron gun), electrons are liberated and then can be
accelerated using a microwave field wave-guide. Due to the need of a rotating gantry, as is the
case of a conventional C-arm LINAC, the accelerator structure is constrained in direction and
bending magnets are introduced to redirect the electron beam through approximately 90◦ in
the direction of the treatment table where the patient is positioned. In this travel, the electrons
collide with a target of high atomic number, usually tungsten, and, from this interaction, the
high-energy bremsstrahlung X-ray photons used in treatment are generated. These photons
are then collimated by a primary collimator and conformed or modulated by the jaws and the
multileaf collimator (MLC).
In the typical clinical energy range (4 MV-25 MV accelerating potential), the angular distribution
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of the bremsstrahlung photons is predominantly in the direction of the incident electrons. This
distribution is, in general, modified by a so called ’flattening’ filter (FF), designed to give an
almost uniform lateral dose distribution to the patient at a specific treatment depth.
In modern clinical linear accelerator this filters typically consist of conical shaped medium/high
Z materials, such as iron, copper or tungsten, and are specific to each particular beam energy.
Bellow the flattening filter, two independent transmission ion chambers provide servo control of
beam steering and dose output, and increment the patient safety preventing possible excessive
radiation output.
In exit to the ionization chamber and just above the exit window of the treatment head, two pairs
of opposing and movable ’jaws’ are responsible for limiting the field size in orthogonal direc-
tions. Further conformation of the beam to the target shape is achieved through the multileaf
collimator (MLC), consisting of 40-160 tungsten ’leaves’, which can be individual positioned.
Fig. 2.4. Electron linear accelerator schematic. Key components are shown that allow a beam of
electrons to be accelerated, producing a treatment beam of electrons or x-rays.
2.2.2 Removal of the flattening filter
Due to the use of the Flatness Filter (FF) some important factors can be observed. For in-
stance, in order to achieve a uniform intensity profile across the whole extent of the beam, a
large fraction of beam intensity at the central axis is removed which decreases the total out-
put. Additionally, the filter generates scattered radiation (with photons and electrons) which
contributes to undesirable dose to the patient and that can be difficult to model accurately in
FCUP 13
Clinical implementation of Monte Carlo simulations of a TrueBeam unit
the treatment planning system (TPS). Also, the photons that penetrates the flattening filter are
subject to a differential amount of absorption depending on which part o the filter they pass
through, leading to ’softening’ of the beam energy away from the central axis (CAX), this results
in a non-uniform spectral distribution and consequently a non-uniform lateral attenuation of the
beam with depth.
Several studies [8][9]investigated the characteristics of non-flattened beams and compared
with the conventional flattened ones. It was shown[9] that without a filter the average photon
energies in a 15 MV clinical beam, measured at isocentre, only varied form 2.9 MeV at central
axis to 2.5 MeV in an annular region 10-25 cm off-axis, whereas for in a conventional flattened
system the mean energies were 4.11 MeV on axis an 3.3 MeV off axis, respectively. More
recent studies [9] also shown that the removal of the Flatness Filter (FF) from the beam line
may solve the problem of increased out-of-field dose to which the large number of photons scat-
tered by the FF make a big contribution. The main reason why Flatness Filter Free (FFF) beams
have not been widely used, is the forward peaked dose distribution or the non-uniform intensity
across the field. However, this difficulty is mitigated for small fields as intensity variations are
minimal over the central 1-2 centimeters of the treatment field. As field size increases, forward
planning may become more challenging and in general, FFF beams are not used for large, un-
modulated fields. Computer optimization, as used in inverse planning, removes the challenges
of the non-uniform fluency. For instance during IMRT planning, a typical broad beam is divided
into many small beamlets to provide sufficient freedom of beam intensity variations required for
IMRT. FFF beams have inherent intensity variations, but these are directly incorporated into the
IMRT plan optimization. In order to prevent the exit of an excessive amount of contaminating
electrons from the accelerator when the flattening filter is removed, recent models with Flat-
ness Filter Free (FFF), like the Varian ’TrueBeam’ have a replacement filter of brass or copper
in order to absorb these electrons.
2.3 Radiotherapy: External Beam treatments
2.3.1 General Techniques
Target depth, size, anatomic site, and proximity of critical structures influence the choice of
treatment modality (photons or electrons) and the technique to be used. The technique param-
eters include the number of beams; beam energy; beam weight (the relative amount of dose
delivered by a beam); field shape; irradiation geometry; and use of bolus, wedges, compen-
sators, or other special devices. General practice is that photons are almost always used in
a combination of two or more fields (i.e., parallel opposed, wedged pair, three field, four field,
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box, or arc) and electrons are used as a single end face fields (perhaps in junction with other
electron fields to cover a larger area). As the number of fields increases, there are two ob-
servations: The high-dose region becomes more conformal to the target, and the peripheral
dose decreases but the volume of tissue covered by peripheral dose increases. Nowadays,
radiotherapy is delivered by using a low number of static fields, or by increasing the complexity
making use of hundreds or thousands of static sub-fields, as delivered by step&shoot IMRT.
Furthermore, dynamic sliding windows IMRT and dynamic arc treatment are more complex
radiotherapy treatments.
2.3.2 Advanced Modalities
3DCRT
Three-dimensional conformal radiation therapy (3DCRT) is a treatment modality in which the
shape of the radiation field is fitted to the contour defined by the projection on the Planning
Tumor Volume (PTV)(The PTV is the volume defined in the patient that contains the tumour,
together with margin for microscopic disease spread, plus an additional safety margin for un-
certainties in planning or treatment delivery)[10] . In other words, it is adjusted to the contour
of the PTV as seen by an observer located at the radiation source, a perspective known as the
Beam’s Eye View (BEV). The field shape is set with the MLC, or custom blocks made of high
density metal.
Fig. 2.5. Beam’s Eye View (BEV) of a Three-dimensional conformal radiation therapy (3DCRT).
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IMRT
The Intensity Modulated Radiation Therapy (IMRT) technique represents a step ahead in terms
of achievable plan quality with respect to 3DCRT. Modulation can be seen as subdividing the
beam in small geometrical subfields named beamlets, each with an arbitrary intensity. This can
be accomplished by computed controlled positioning MLC leaves [11]. Brahme[12] showed
that if the intensity is modulated across the radiation field a better dose distribution is achieved.
Two alternative approaches to the delivery of IMRT using LINAC and MLC are commonly em-
ployed, they are the step-and-shoot and the sliding window techniques. The former utilizes a
sequence of multiple fields (segments) of varying shape. The beam is turned on to irradiate
each field when the leaves are not moving. The number of segments can be from a few to
several hundred. In the sliding-windows technique leaves are continuously moving while the
beam is active.
VMAT
Intensity modulated arc therapy was first proposed by Yu and Tang [13] as a generalization of
the IMRT concept. It consists in delivering the intensity modulated treatment during the contin-
uous rotation of the LINAC gantry. Yu predicted that by increasing the number of gantry angles,
the number of intensity levels at each gantry angle can be reduced without degrading the plan
quality. In 2008 the first commercial implementation of intensity modulated arc therapy (IMAT)
was available. It appeared with the trade name of RapidArc and was marketed by Varian Med-
ical Systems. RapidArc implements the algorithm developed by Otto [14] which includes more
degrees of freedom to the dose delivery, i.e., the rotation of the gantry with variable speed and
also a variable dose-rate. In addition, it uses progressive beam angle sampling to optimize a
large number of apertures. The term VMAT, introduced by Otto, is widely used to identify the
single-arc IMAT technique that uses variable dose-rate.
The increased complexity of the treatment requests an appropriate level of quality control to
maintain safety for the patients. On the other side, an increase in the technological capa-
bility of shaping the dose to the target, allows a reduction of the doses to the organ at risk,
reducing undesirable effects such as secondary induced tumors. Reducing the uncertainties
during the treatment by best delivering dose to the target, allows dose escalation programs, in
which a higher fractional dose is delivered in a single fraction. This approach has numerous
advantages, from a radiobiological point o view and determining a lower number of treatment
sessions per patient with clear benefit for the patient and for the Radiotherapy Departments
schedules.
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2.4 Monte Carlo
Monte Carlo (MC) is a general approach for numerical integration that is applied to several
fields, from statistics to economy from medicine to physics. It is a useful technique for a wide va-
riety of situations with a complex structure of probabilistic nature as is the case of the radiation
transport in matter, where analytical approaches can be inadequate. MC is used in Radiother-
apy as a numerical technique to simulate the trajectories of particles by using (pseudo)random
numbers to sample the statistical distribution of the physical processes involved. The probability
distributions used are derived from the underlying physical properties of the processes.
The main idea behind using Monte Carlo method is to estimate the most expected value
of some variable. If this variable is obeying a uniform distribution function then this will be
equivalent to finding the mean. Numerically the expected value E(f) of a function f(u) is
calculated as:
E(f) =
∫
f(u)g(u)du
with g(u) being the probability density function. For a uniform distribution function defined
in the interval [a,b]
E(f) =
1
b− a
∫ b
a
f(u)du
Considering a true random number ζ, 0 ≤ ζ ≤ 1, homogeneously distributed in the interval
[0,1], the by the ”law of large numbers” the expected value can be found as
E(f) =
1
N
N∑
i=1
f(ζi)
The random sequence ζi, ζi+1, ..., ζN must be generated using a good Random Number Gen-
erator (RNG). These generator use different techniques. One of the most used techniques is
the multiplicative linear congruential RNG, which uses the formula
ζi = (Aζi−1 +B)moduloM
Then with a first random number ζ0, a seed M and constants A and B a particular sequence of
random numbers can be generated.
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2.4.1 Monte Carlo Method for Radiation Transport
The Monte Carlo method uses random numbers to solve problems numerically. Propagation of
radiation through matter is a process in which primary particles with a given energy penetrate a
material medium suffering a series of interactions in which energy is transferred to the medium
and secondary particles are produced. Although the principles of the interaction of particles
with matter are well known, the mathematical description of the successive interactions under-
gone by an ensemble of particles is a complex problem, generally solving Boltzam transport
equation, but it can be easily simulated with the Monte Carlo method. The application of the
Monte Carlo method for radiation transport consists of the following steps:
i) A primary particle is generated in an initial state determined by its position, flight direction
and kinetic energy.
ii) The particle is moved to a new position along a straight line following the initial direction of
flight (This assumption is valid in the absence of electromagnetic fields and when coherent
effects are negligible), where the next interaction event is assumed to take place; the trav-
elled distance is sampled from a decaying exponential probability distribution characterized
by the mean free path of the particle in the material medium.
iii) The type of interaction is randomly selected according to the point probabilities associated
to the cross sections of the considered interaction mechanisms.
iv) The interaction is simulated by changing the dynamical state of the particle and, possibly,
generating secondary radiation.
v) The process starts over at step ii) .
vi) and it is repeated until the particle is locally absorbed or when it escapes the material
system.
Secondary particles are subsequently simulated in the same manner. The simulation of a
primary particle and its descendants is called a ‘shower’ or a ‘history’. As every numerical
estimators in Monte Carlo, the solution is affected by statistical uncertainty, that is connected
with the number of simulated histories and, consequently with the total calculation time.The
simulation stops when a user-defined number of simulated histories or a desired level of sta-
tistical uncertainty is reached. The relevant quantities of the problem under study are tallied
at the proper steps of the simulation of each particle and their averages are obtained after all
histories have been completed. Owing to the stochastic nature of the Monte Carlo simulation
the tallied quantities have an inherent statistical uncertainty.
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The simulation algorithm described above in steps (i) to (v) is known as detailed simulation.
When the mean free path between two consecutive interactions is small compared to the to-
tal distance travelled by a particle before it comes to a halt, the number of interactions to be
simulated is extremely large and, therefore, detailed simulation becomes very slow. This is the
situation found for charged particles, especially at high energies as those found in radiotherapy.
For photons the number of interactions undergone is relatively low and detailed simulation is af-
fordable. The problem for charged particles can be overcome by using the so-called condensed
transport schemes, in which the effect of multiple interactions is described collectively in a sin-
gle artificial step [40]. The total energy loss and angular deflection of the particle occurring
along a step length is sampled from probability distributions obtained from multiple-scattering
theories [47, 48, 75, 73]. In his seminal work Berger classified condensed-history method in
two classes [12]. In class I algorithms the length of the step is predefined. This scheme may
present problems at the interfaces of two different materials because some steps may not be
fully contained within a single material medium, a necessary requirement for the underlying
multiple scattering theories may be applicable. These limitations motivate the introduction of
refinements in the algorithms such as progressively reducing the step length as the particle
approaches an interface. In contradistinction, class II algorithms (Also referred to as mixed
simulation schemes) select lengths stochastically. This scheme is based on classifying inter-
actions into soft and hard events. Soft events involve energy losses and angular deflections
below certain user defined cut-offs. The remaining interactions are classified as hard and they
are simulated with detail, which implies that the distance between two consecutive hard events,
the step length, is randomly sampled according to the usual decaying exponential distribution.
The accuracy of the transport algorithm may depend on the selected step length, that is, on
the selected cut-offs to distinguish hard from soft events. Usually, shorter steps imply better
accuracy at the expense of a lower simulation speed.
2.4.2 Application to radiotherapy
In the radiotherapy field the Monte Carlo (MC) methods are applied with several intents like radi-
ation dosimetry, treatment planning, quality assurance (QA) and design of treatment devices[1].
The Monte Carlo (MC) method can provide information that cannot be obtained by direct mea-
surement or analytical calculations.
It is known that the Monte Carlo method applied to the simulation of external beam ra-
diotherapy is capable of computing accurate absorbed dose distributions and that in general,
the accuracy obtained from a Monte Carlo simulation in the dosimetry of external radiotherapy
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plans of photon or electron beams is better than that yielded by treatment planning systems
based on non-stochastic algorithms[15]. That is because non stochastic algorithms use simpli-
fications to allow analytical calculations taking into account beam and dose deposition models
based on measurements such as Percentage Depth Dose (PDD) and dose profiles, and intro-
ducing analytical refinement considering the non homogeneity of the treatment area in terms
of density.
In Monte Carlo (MC) simulation, the history or track of a particle is viewed as a random
sequence of free flight that ends with an interaction event where the particle change direction,
loose energy and occasionally, produces a secondary particle [16].
To simplify the radiation transport simulation a number of considerations were adopted. At
first, the force between the incident particles (electron or photon) is considered to be negligible.
These particles are referred to as primary or secondary depending if they enter the medium
or if they are produced inside it, respectively. Both the primary and secondary particles are
supposed to move in straight lines between interactions. Each material medium is considered
homogeneous and isotropic. The atoms are assumed to be randomly distributed with uniform
density. To simulate radiation transport the probability of each interaction at the end of each
step, dependent of energy and material electronic density is given by the cross section de-
scribed before.
2.4.3 Monte Carlo codes
Several extensive reviews of the existing Monte Carlo codes were produce along the years,
therefore here will be made a condensed resume based on the work of Brualla [17]. In radiation
transport, a number of MC general purpose codes exist, but some of them are more adapted to
the problems encountered in radiotherapy. The most known are PENELOPE , EGSnrc , MCNP
and GEANT. PENELOPE and EGSnrc codes are restricted to electron/positron and photon
transport, whereas MCNP and GEANT may simulate many other particles, like neutrons or
protons. PENELOPE and EGSnrc are therefore focused on the particles of interest in medical
physics and MCNP and GEANT have shown less accuracy and/or more sensitivity to transport
parameters than those. Nonetheless, MCNP and GEANT can handle particles like neutrons
and protons produced at high nominal energies (18MV or higher) in the treatment head and
that may have a significant contribution to dose to the patient.
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2.4.4 PENELOPE Code
PENELOPE is the code used by PRIMO for the simulation of LINACs and the estimation of the
absorbed dose distribution in phantoms and CT geometries. PENELOPE simulates the coupled
transport of electron, photons and positrons in the energy range form 50 eV to 1 GeV and uses
a mixed simulation scheme, where a class II algorithm is used for electrons and positrons, while
photons are simulated in detail.
The user defined transport parameters that control the behaviour of the mixed algorithm
are:
• C1→ determines the average angular deflection between consecutive hard events.
• C2→ limits the maximum average fractional energy loss between consecutive hard events.
• WCC→ is the energy cutoff that separates hard from soft interactions for inelastic colli-
sions with atomic electrons.
• WCR→is the energy cutoff for bremsstrahlung emission.
• DSMAX→ is the maximum allowed step length for charge particles.
• EABS→are absorption energies at which the transport of the corresponding particle
(electron, photon or positron) is terminated and the remaining energy is assumed to be
locally deposited.
The software package includes a set of geometry subroutines, named PENGEOM, capable
of handling objects limited by quadric surfaces. The geometry is coded in a text file according
to a series of syntax rules. Surfaces are defined by declaring the parameters of a quadric
equation and bodies are defined by declaring their limiting surfaces. Objects can be translated
and rotated arbitrarily. PENELOPE requires a main program to steer the simulation and to
define sources and tallies. Several main programs are distributed with the code. PENEASY
[18] is an independent main program that implements a wide variety of configurable sources,
tallies and variance reduction techniques. Apart from taking advantage of the capabilities of
the standard PENGEOM subroutines to simulate quadric geometries, PENEASY additionally
includes a package named PENVOX which handles the transport in voxelized geometries. In
PRIMO a combined system PENELOPE/PENEASY is used.
2.4.5 PRIMO system
PRIMO[19] it is a self contained software that simulates the radiation transport through the
whole linac head and a binned water phantom or a CT of a patient using the general-purpose
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Monte Carlo code PENELOPE2011. The system supports all the range of Varian Clinac C-
series (18,21,23,iX,etc.), 600, Unique Truebeam, and Elekta SLi and MlCi series [20]. The
linac geometries are part of the package, and the user is not required to enter any geometrical
or physical information of the linac. Being a compiled and closed code, PRIMO does not allow
to define new geometries and the user is limited to choose from those provided by the software.
PRIMO can produce PHSP at the downstream end of the upper and lower parts of the linac
and can import external PHSP provided they are compliant with the IAEA specification [21].
For each simulation users can assign values to the initial beam parameters which are: primary
electron beam energy Full width at half maximum (FWHM) of the primary energy distribution,
FWHM of the focal spot size, and beam divergence. The code provides suitable default initial
parameters for most available linacs and nominal energies. Users can fine-tune these param-
eters to obtain a better match between the simulated and the experimentally measured depth
dose and lateral profiles of reference fields. The code does not provide a beam configuration
algorithm. Therefore, the user must perform several simulations varying the primary beam en-
ergy parameters until finding the most adequate ones that reproduces the experimental depth
dose profiles and then vary the FWHM of the focal spot size until reproducing the lateral dose
profiles. To reduce simulation time the code incorporates a number of specifically developed
variance-reduction techniques [1], namely, the movable skins technique, splitting roulette, rota-
tional splitting and fan splitting. Other variance-reduction techniques are also available such as
interaction forcing in the linac target to maximize the bremsstrahlung production and standard
particle splitting in the patient. Additionally, the simulation can be distributed among the cores
in a computer. There are two geometry models (patient models) available for dose calculation
that can be chosen in segment s3 setup, namely, a homogeneous water phantom and a com-
puterized tomographic volume. The water phantom is the default selection. A slab phantom is
another geometric possibility, and is treated by PRIMO as a CT volume. The patient represen-
tation is a binned 3D matrix created from the CT scan which is imported from a DICOM file.
In the same way, phantoms of slabs and homogeneous phantoms can be created directly in
the program. PRIMO includes 40 clinically relevant materials in its database, which are used
to convert the Hounsfield Units (HU) into material composition. The volume segmentation is
done by assigning up to 10 CT intervals from the 40 referred materials. The CT scanner cal-
ibration curve is used to assign mass densities to CT numbers. A default curve that can be
edited by the user is also provided by PRIMO. The system allows to import anatomical struc-
tures from DICOM-RT STRUCT files or delineate them through the contouring functionality.
The analysis tools include the creation of probability distributions from PHSP, the production of
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dose-volume histograms, dose profiles and comparison of experimental dose measurements
with Monte Carlo estimated dose distributions using the gamma index. All these features are
wrapped under a graphical user interface and runs on Windows. PRIMO is a full Monte Carlo
and a self-contained system which can be used for dose verification and research purposes. It
is freely distributed from the website http://www.primoproject.net.
2.4.6 Dose assessment in the patient
The radiation field resulting from a linac simulation can be used to estimate the absorbed dose
distribution in a patient CT or a phantom. Radiation transport in Monte Carlo algorithms relies
on the knowledge of interaction cross sections for the material media traversed by particles, so
to be able to perform the simulation in a CT geometry it is necessary to infer both the material
composition and the mass density from the information provided by the CT scanner in terms of
the so-called Hounsfield units HU, defined as
HU = 1000× (µ− µwater)
µwater
Where µ and µwater are the average linear attenuation coefficients of the material of interest
and of water, respectively, both determined for the radiation quality of the scanner.
A simple method used to inferring the material composition and mass density for each
voxel is to select materials for a predefined set according to the linear mapping experimentally
obtained between H and density.
Misassignment of material composition resulting from a poor CT-to-material conversion pro-
cess can have an impact on the dose, with errors in the dose up to 10% for 6 and 15MV photon
beams and up to 30% for a 18 MeV electron beam. From the 3D dose distribution matrix, ob-
tained from simulation can be reported the 1D dose profiles, 2D dose maps, isodose lines and
dose-volume histograms (DVHs). The dose distributions are generally compared by means of
relative differences and with the gamma index. The increasing clinical application of Monte
Carlo method has raised the question of whether the dose-to-medium Dm, which is the dose
estimated by Monte Carlo codes, or the dose-to-water Dw, the one historically calculated by
treatment planning systems, should be specified. Relative differences between Dm and Dw are
given by unrestricted mass collision stopping power of water to medium (S/ρ) and are of the
order of 1%-2%, hence considered not clinically relevant for tissues with media composition
similar to water, with the exception of bone, where differences can be as high as 15%. Sta-
tistical uncertainties are inherent to dose distributions estimated with the Monte Carlo method
and consequently isodose lines exhibit a jagged appearance that may confound visual evalu-
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ation of the dose distribution. Integral dose quantities such as DVHs are less affected by the
uncertainty, however steep DVHs, such as those of PTVs, are significantly smoothed when cal-
culated from distributions with a large uncertainty. This effect is less pronounced in DVHs of
critical structures due to their shallower slopes. When analysing dose limits to critical organs,
for instance, the level of acceptable uncertainty is relative to the biological effect produced by
the dose on a particular organ. The biological effect on serial organs, such as the spinal cord,
is exclusively dependent on maximum dose values, therefore demanding a low statistical un-
certainty for their estimation. In contradistinction, biological effects on parallel organs, such as
the lungs depend on mean doses. It has been suggested that a relative statistical uncertainty
of 2% of the maximum dose (Dmax) is acceptable in evaluating a Monte Carlo base treatment
plan. However, the uncertainty of a single voxel is a poor measure for the uncertainty of a treat-
ment plan and have been proposed the mean uncertainty of a volume determined by all voxels
accumulating a dose greater than Dmax/2 as a convenient indicator of the overall uncertainty of
a dose distribution. Where for estimating the mean statistical uncertainty σV of a region V the
summation in quadrature of the relative uncertainties of all voxels in V is done,
σ¯V =
√√√√1
k
K∑
k=1
σ2
where K is the number of voxels in V and σk is the relative statistical uncertainty of the dose in
voxel k.
2.5 Simulation of Linear Accelerators
The description of the radiation beam leaving a medical linear accelerator can be obtained by
two approaches:
1. Based on the so called virtual source model, which approximate the particle fluence
downstream the head assembly by considering the major linac components as sepa-
rate particle sources. The virtual source models are classified into three groups: (i) those
that solely use pre-calculated data from Monte Carlo simulations, (ii) hybrid models in
which the planar fluences and energy distribution derived from Monte Carlo simulations
are adapted to match measured dose profilesand (iii) those based on measurements.
2. Performing a full Monte Carlo simulation of radiation transport through a detailed model
of the linac head. In principle, virtual source models are less accurate than Monte Carlo
approach.
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In the Monte Carlo approach the simulation of a linac starts by modelling the primary source
of particles as a narrow beam of electrons exiting the acceleration structures and entering
the head assembly. Knowledge of the characteristics of the initial particle states (i.e., energy
distribution, spatial distribution and angular divergence) is necessary for accurately reproducing
the actual treatment beam. The simplest model assumes that a monoenergetic and collimated
electron point source is located at the top surface of the target and directed downstream along
the treatment head central axis. A more elaborate model assumes that the energy particles of
an electron beam have Gaussian distributed energy, with defined mean and FWHM. In addition,
the model assumes that the particles are directed with an angular divergence distribution. A
suitable configuration of the primary electron source can be found in an iterative trial-and-
error procedure in which dose profiles estimated in simulations are compared to measurements
water phantom. Primary beam information provided by manufacturers might be used as a
starting guess in this iterative procedure and some Monte Carlo treatment planning systems
incorporate algorithms to try to avoid the application of this trial-and-error procedure.
To compute the dose distribution in the patient, particles must be transported through the
upper structures of the linac, the patient dependent beam modifiers and, finally, through the
computerized tomography (CT) or phantom. However, this may be an inefficient method. In
principle, a more efficient approach is to simulate the upper part of the linac, from the primary
beam downstream to a plane situated just upstream the jaws, and to save the state of particles
reaching that plane in a file. This simulation has to be performed only once per beam. The
file tallied at the aforementioned plane, which is known as the phase-space file PHSP, is used
as a source of particles for subsequent simulations. It is not infrequent that a second PHSP is
tallied at treatment head exit and used for dose estimation in the patient.
In general, the simulation of a linac can be divided into three parts:
i) the simulation of the linac components located upstream the movable collimator (upper
part);
ii) the simulation of the linac components located upstream the movable collimator (upper
part) and the simulation of the movable collimators themselves and all other linac compo-
nents downstream them (lower part);
iii) computation of the distributed dose through the computerized tomography (CT) represent-
ing the patient.
A full Monte Carlo system simulates all the three parts while the virtual source models only
simulate the radiation transport through the CT, item iii).
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2.5.1 Phase Space Files
A phase space file (PHSP) contains all the information relative to the particles passing through
a specific plane. It is a database that stores the state of the particles in terms of type of
particle (electron, photon, positron, etc.), energy, position in Cartesian coordinates (x, y, z)
and direction cosines (u, v, w) are always stored[21]. As each user can define its own PHSP
structure the IAEA proposed a unifying standard structure as in Table 2.1. As for this standard,
the minimum space occupied in the binary file by the information relative to one particle is
25 bytes. Optionally, some other information may be stored as is the case of the incremental
shower number that permits to create a relation between a particle and its history for further
statistical uncertainty calculation. This number indicates how many histories (showers) were
simulated between each tallied particle and the previous one in the sequence of particles in
the PHSP. For example, if two consecutive particles in the PHSP belong to same history, the
second particle will have its incremental shower number equal to zero. This approach allows
separating information about primary and secondary particles.The summation of all incremental
shower numbers in a PHSP yields the number of simulated histories. Another approach to
relate each particle with its history number is to tag each particle in the PHSP with a flag that
indicates when a change of history has occurred, and to provide with the PHSP the number of
simulated histories that was used for its computation. This approach yields the same accuracy
than the incremental shower number in the estimation of the statistical uncertainty of quantities
tallied using the PHSP as radiation source, provided the whole PHSP is used. If only a fraction
of the PHSP is used an approximation to the statistical uncertainty can be obtained by assuming
that all histories have contributed with the same number of particles to the PHSP. The finite
size of a PHSP imposes a lower bound to the statistical uncertainty of observables tallied with
it, and the minimum statistical uncertainty that can be asymptotically reached using a given
PHSP is called the latent variance. Reusing particles in a PHSP is a way to approximate
the uncertainty of the estimated quantities to the latent variance of the PHSP, however, when
recycling a PHSP, it is critical to maintain the correlation between particles pertaining to the
same history, otherwise uncertainties will be erroneously underestimated. A convenient way
to reuse τ times a PHSP without loosing the correlation of the particles of one history is to
split τ times the particle entering the simulation and to treat the original particle and the clones
as pertaining to the same history, as seen before in the particle splitting Variance Reduction
Technique (VRT). As each code has its own proprietary phase space file (PHSP) format, for the
purpose of consistency an effort to standardize it was made by the International Atomic Energy
Agency (IAEA) that has defined as PHSP format used in their PHSP database [21]. The IAEA
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specification consists of two files, a header file that contains general information (such as the
number of histories that were simulated to produce the PHSP, the number of particles stored
and the byte order) about the way the related binary file stores the data for every particle tallied.
The IAEA has made available a library of subroutines written in the C/C++ language to handle
its PHSP format by the main Monte Carlo codes.
Variable Meaning Type of variable
returned
x Position in X direction in cm Real*4
y Position in Y direction in cm Real*4
z Position in Z direction in cm Real*4
U Direction cosine along X Real*4
V Direction cosine along Y Real*4
E Kinetic energy in MeV Real*4
Statistical Weight Particle statistical weight Real*4
Particle Type Type of the particle Integer*2
Sign of W Sign of W (direction cosine in Z) Logical*1
Is new history Signifies if particle belongs to new history Logical*1
Integer extra Extra storage space for variables(e.g.,
EGS LATCH, incremental history num-
ber,PENELOPE ILB, etc.)
n*(Integer*4)
(n≥0)
Float extra Extra storage space for variables(e.g., EGS
ZLAST)
m*(Real*4)
(m≥0)
Table 2.1: Information to be returned from a PHSP
As a general rule IAEA recommends to use about 10000 primary particles per unit area of
interest to obtain an approximate 1% statistical uncertainty and that the minimum number of
particles per unit area for radiation therapy fields should be around 2500 particles/mm2 at the
isocentre plane. The actual number of particles to use requires additional investigation with
respect to the latent variance (the minimum statistical uncertainty that can be asymptotically
reached using a given finite size PHSP).
2.5.2 Variance Reduction
The efficiency η of computational calculations is defined by the following equation:
η =
1
σ2T
where T is the calculation time and σ2 is the variance. In Monte Carlo calculations, the variance
is proportional to the inverse of the number of histories N and can be written as
σ2 =
∑N
i=1(Xi − X¯)2
N
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So there are two possibilities in order to increase the efficiency, reduce T or σ. For most of
the Monte Carlo algorithms T is constant and can be reduced only by changing the algorithm
implementation, so the alternative is to reduce the variance which is achieved through the use
of the so called Variance Reduction Technique (VRT). This techniques are time consuming and
can affect the accuracy of the evaluated tally therefore its use must be balanced.
In many cases there is no interest in following a particle that go outside a user-defined volume
of interest and stopping the tracking when it exit from such a volume reduce te computational
time. When VRT are used, a statistical weight is associated to each particle. As an example,
when using interaction forcing n, so that a particle interaction with production of secondaries
(as is the case of photon production by electron-target interaction) the statistical weight of each
of the secondaries is 1/n. This means that every secondary photon produced by the same
primary counts conts for 1/n. In some cases, it is preferable to discard from tracking the parti-
cles that get statistical weight under a predefined threshold. As a further example, this criterion
is active when executing the Russian Roulette technique, where the idea is to eliminate the
particles with specific probability and depending on their positions, direction or weight. When
this particles are removed the weight of the remaining are increased in order to maintain fixed
the statistical weight of a history.
Other methods to reduce variance is to force a particle to go through the volumes of interest.
One way to achieve this is to copy a number of particles with suitable position and direction and
using them in simulation, this is called particle splitting technique. In this technique, the copied
particles, although with the same starting position and energy of the original will propagate
through a new random path. The statistical weight is divided between the original and copied
particles to keep the statistical balance of the simulation.
In the interaction forcing VRT technique , the particles are forced to interact with specific proba-
bility when they pass through the volume of interest, which is an efficient technique to increase
the bremsstrahlung radiation resulting from the electron interaction with the target.
some techniques of VRT rely on the true physics instead of random sampling, as is the case
of the exponential transform techniques in which the path lengths are adopted according to the
rule of exponential attenuation of particles instead of its random sampling.
For any simulation there is a level of particle energy under which the interactions of particles
has no important contribution for the evaluated tally and in addition, the number of interactions
to compute is still high. Therefore a cutt-off energy value is defined to reduce time and particles
are not tracked anymore when reaching energy below such value. In order to keep energy
conservation, the remaining energy is assumed to be deposited in the last step of the particle
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or, in other cases the continuous slowing down can be assumed. This VRT introduces a bias
in the final estimation of tallied energy deposition in a point.
2.5.3 Evaluation of results of a numerical MC calculation with respect to exper-
imental measurements
Gamma Function
To evaluate if a plan is adequate it is necessary to compare quantitatively way the calculated
dose with a reference. The background to this approach is that MC makes use of models
to simulate interactions, geometries, particles and physical properties. A model can be close
to reality and give good results or far from being real and give not acceptable results. The
basic idea behind the Gamma Function approach is that a reference is considered as the truth,
while the MC model is an attempt to reproduce the reality. In Radiotherapy, if the evaluation is
done during the plan elaboration, the reference dose will be the prescribed, i.e., it will be the
dose indicated by the radio-oncologist. In other cases, e.g. validation of Monte Carlo (MC),
the reference dose is obtained from the experimental measurements and the calculated dose
results from the MC simulation. In either case, the objective is to compare the calculated and
reference dose distributions.
For this evaluation is usually used the so-called the Gamma index and has been used to
evaluate the algorithms for dose calculation against the dosimetric measurements since its
introduction[22]. The gamma criterion is based on the definition of an acceptance region that
is represented by an ellipsoid defined by
Γ(~rc, Dc) =
√
∆r2
∆d2M
+
∆D2
∆D2M
= 1
where ∆r = |~rr − ~rc| is the distance between the calculated and the reference points and
∆D = D(~rc) − D(~rr) is the doses difference. In order to the evaluated distribution coincides
with the reference its necessary that at least one point verifies Γ(~rc, Dc) ≤ 1. considering the
quality factor, as the minimum value, i.e.,
γ(~rr) = min{Γ(~rr, Dc)}∀{~rc}
the acceptance-rejection criteria becomes:
• γ(~rr) ≤ 1, the dose compares adequately with the reference
• γ(~rr) > 1, the evaluated dose is not equivalent to the reference.
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The Distance To Agreement (DTA) is the distance between the point that is being evaluated and
the closest point of the reference dose distribution and this concept was introduced because
dose difference in the high dose regions can be large but of little importance compared with
other uncertainties. The dose difference and the DTA are complementary parameters and so an
evaluation can be considered adequate not only if it has a low dose difference but also if it has a
relative high dose difference but at the same time a DTA that is inferior to the treatment precision
or to the security margins defined. The Gamma criterion combines in a single indicator the
dose difference and the DTA where the acceptance criterion is the difference (or distance) in
the multidimensional space of dose and physical distance between the points. The gamma
analysis index (γ) is sensible to the statistical noise [23], which means that special care must
be taken in computation with the use of small voxel sizes with high statistical uncertainties.
This can lead to improperly accept a plan that would fail the test in a no-noise condition or
vice-versa.
2.6 Monte Carlo simulation of IMRT and VMAT
IMRT and VMAT techniques involves dramatically different approaches in treatment planning
and dose delivery. Thus, conventional dose calculation methods based on scatter summa-
tion and water-phantom measurements are becoming inadequate for obtaining accurate dose
distributions for this dynamic modalities. On the other hand, with the fast growing computer
technology, methods based on the first principles of radiation transport, such as Monte Carlo
simulation, are evolving into the standard of practice for the need of more sophisticated dosime-
try tools. Several research efforts have been focused particularly on Monte Carlo simulation for
the IMRT in order to answer a full range of questions from three-dimensional treatment planning
to clinical dosimetry [24] [25][26]and more recently a complete QA system worflow for VMAT
[27] and a PRIMO IMRT implementation study [28].
2.6.1 The dynamic motion of the MLC - SCS and PPS approaches
An additional challenge to radiation dosimetry posed by IMRT and VMAT techniques, including
for Monte Carlo simulation, is the time dependent factor that may have to be incorporated in
dose calculation and measurement for these dynamic beam delivery systems. To approach
this issue there are two approaches to this problem with Monte Carlo in order to simulate the
motion of the collimators, for intensity modulated (IM) or dynamic fields. A more rudimentary
method referred to as the Static Component Simulation (SCS), is based on the simulation of
each sub-beam segment of a sequence of static configurations individually, as in the case of
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step-and-shoot IMRT, and integrating the results from all component fields in the end. For
IM fields with a large number of segments that could exceed 100, this method may become
cumbersome in order to track results from all the segments. Alternatively, a Position Probability
Sampling (PPS) approach can be used to represent the motion of the dynamic components
by randomizing its position during a simulation[5]. This technique was first proposed in a work
for modelling dynamic wedges delivered by sweeping the collimator jaws [2]. Compared to the
SCS method, the PPS method is more automated and efficient from an operational point of view
and the principle of the PPS method can be extended to simulate other dynamic motions, and
in particular, sliding windows intensity-modulated beams using multileaf collimators, with the
advantage that a PPS method simulation can be accomplished in one single run, improving the
operational efficiency, and the degree of fidelity of the simulations in the condition of continuous
dynamic collimator motion.
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3. Implementation
After the previous work [28] done in the simulation of IMRT with PRIMO software, realized at
IPO, the current work aimed at extending the results to the VMAT treatment modality and to
design a workflow that allowed to introduce the simulation in the clinical practice. This would
involve the development of an application that would help to configure, with the aid of a graphi-
cal user interface, the PRIMO system with the wanted modulation to simulate.
As of the starting of this work a new Varian TrueBeam Linac, with the Flatness Filter Free (FFF)
operation mode had been installed and commissioned at IPO and no MC model existed, all
the work was conducted in order to that this linac would be the main equipment and so all the
MC modelling and the respective validation tests to be performed become another inevitable
objective of this work.
3.1 Materials
3.1.1 Varian TrueBeam Linac
TrueBeam is a clinical linear accelerator, manufactured by Varian. The system dynamically
synchronizes imaging, patient positioning, motion management, and treatment delivery. It is a
versatile platform which can be used for all forms of advanced radiotherapy modalities including
Image Image Guided Radiotherapy (IGRT) and Image Guided Radiosurgery (IGRS), Intensity
Modulated Radiation Therapy (IMRT), Volumetric Intensity Modulated Arc Therapy (Rapid Arc)
and Stereotactic Body Radiotherapy (SBRT) along with conventional and 3-D conformal radio-
therapy. Adding to this has the possibility of operate in Flatness Filter Free (FFF), or ”High
Intensity Mode” as Varian refers to it, at the 6MV and 10MV energies.
This linac is equipped with a 120 HD MLC system.
3.1.2 PRIMO
As described in 2.4.5 PRIMO is a software that simulates clinical linear accelerators (linacs)
and estimates absorbed dose distributions in water phantoms and computed tomography (CT).
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It combines a graphical user interface and a computation engine based on the MC code PENE-
LOPE, generating all the necessary input files need by this one for simulating a variety of linacs.
The version 0.1.5.1307 of PRIMO was used through this work.
3.1.3 treatment planning system (TPS)
The treatment plans used in the various simulations were done using the Eclipse TPS system.
3.1.4 The Control Point
The representation of a dynamic treatment by a calculator poses the problem of representing
a continuous motion using discrete states. The most intuitive and straightforward approach is
to use a number of discrete configurations to represent the system trajectory. These points are
known as the Control Points (CP), assumed as snapshots of the system at discrete time con-
ditions. The sequence of the control points represents the system trajectory. In Radiotherapy
a control point consists on information on gantry angle, jaws position and one value per each
leaves of the MLC as function of time. In the case of radiotherapy systems, the time axis flowing
is replaced by another quantity that is the MUindex. The MUindex is the cumulative monitor unit
value normalized to the total of MUs at specific control points. Consequently, MUindex is a value
that runs between 0.0 at begin of the treatment and 1.0 at the end and it is directly related to
the time only in the case of fixed dose rate. A CP can be viewed as the source of trajectory
information or as the source of configuration itself. The MC based TPS calculate the dose at
the planned control points, but alternative algorithms can be developed, in order to redefine the
steps between the MUindex of consecutive CPs or to randomize the sampling method of CPs
as by the PPS approach.
3.1.5 DICOM plan file
The TPS communicate with the LINAC and the Record and Verify systems through DICOM
files. The plan informations are stored in a DICOM file usually name as RP.xxx.dcm. Once
open with specific software, it is shaped as a structure with registered information allocated in
specific cells. This structure contains the geometric and dosimetric data specifying a course of
external beam, e.g., the number of beams, beam angles, collimator openings, beam modifiers
and the control points sequence.
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3.1.6 mlc modulation file
The TPS calculates the MLC motion and offers the possibility to the user to export a file, which
contains information on the motion of every single leaf during the delivery. This file simpler than
the RP DICOM file as it does not contain any information on other components as the jaws or
the gantry. This file can be used as a modulation information source when the gantry is fixed
as in the case of IMRT procedures. It is structured in a sequence of positions, one per leaf at
specific moments during the treatment.
3.1.7 Trajectory log file
During treatment, the TrueBeam system records actual axis positions and MU delivered. After
the treatment is completed, this information is stored to a trajectory log file so that the informa-
tion can be retrieved and evaluated. The output file is binary with snapshots of the system with
a sampling interval of 20ms.
3.1.8 Workstation
All the simulations were performed with a worksation present at the IPO research lab with a
Intel(R) Xeon(R) CPU E5-2660 v3 @ 2.60GHz with 16GB of RAM and with 32 CPU cores
available.
3.1.9 Measurement materials
For the measurements, two types of phantom were used. For the static and IMRT type fields, a
multislab RW3 box was constructed. For the case of VMAT the OCTAVIUS4D R©phantom was
used. In either case Gafchromic films were inserted between two slabs at a specific depth in the
phantoms to allow comparison between simulations and experimental dose distributions. The
Dose distribution images were obtained by scanning the Gafchromic film with an Expression
10000XL scanner (Seiko Epson Corp., Nagano, Japan). The conversion from Optical Density
(OD) to absorbed dose was done with DOSELAB R©from PTW, using 24h pre-calibrated curves.
3.1.10 Matlab R©
All the modules of the in house developed application were coded with Matlab R2016a from
Mathworks R©. MATLAB R©(matrix laboratory) is a multi-paradigm numerical computing envi-
ronment and fourth-generation programming language. A proprietary programming language
developed by MathWorks R©, it allows matrix manipulations, plotting of functions and data, im-
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plementation of algorithms, creation of user interfaces, GPU and parallel processing as well as
interfacing with programs written in other languages.
3.2 Method
3.2.1 Verification and Validation
Beam
The first step in order to proceed with the work is to get a validated model of the beams pro-
duced by the linac. For that, the first approach was to use the linac model FAKEBEAM included
in PRIMO as the good results showed in (Belosi)[29]. The first iteration values used for the
requested parameters such as the number of histories, energy and space Full width at half
maximum (FWHM) and beam divergence, were the same as those of the [29](Belosi et al.)
study. After this the process consisted in a successive parameters refinement in a cyclical
model tuning.
A different workflow is offered by the IAEA, which provides some PHSP free to download for the
MC community through the open IAEA database. PRIMO allows to import such IAEA PHSP s1
stage in standard format as discussed in 2.5.1. The import of the IAEA PHSP files requested to
adapt the files into a specific format. As mentioned before, the PRIMO is based on PENELOPE
and is able to track only electrons, positrons and photons. The IAEA PHSP may be produced
by another code (e.g., in this case with GEANT4), which are able to deal with other types of
particle. Ann in-house code was developed to delete the undesirable particles form the PHSP
in order to use it in PRIMO. The fraction of deleted particles was negligible. Unfortunately, al-
though PRIMO successfully imported the files it always gave an error when trying to simulate
the s2 stage. Following this approach the set of PHSP files provided by Varian were download
from Varian site. There were about 50 files available for each of the energies, 6FFF, 10FFF and
15X with sizes of around 1GB each. These PHSP were collected above the movable jaws. The
Table 3.1 gives a summary of the contents of the stored Phase Space, as extracted from the
respective accompanying header files.
Later, a new project was created for each energy and choosing the model Varian 2100 in
PRIMO as recommended in the PRIMO manual. Only a number of 5 PHSP files were used in
all the three cases. The statistics using this number of files is well higher than the the minimum
number of histories recommended by the IAEA, and above the 2 × 109 number of histories
benchmark of other studies [29].
A first consistency check was done with this resulting phase space, running a simulation
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through the stages s2 and s3 with the largest field possible (40 × 40cm2) in a water phan-
tom. Comparison with the reference measured dataset available from the linac commissioning
were performed. After this starting point, the beam model was commissioned with respect to
a larger dataset. The whole dataset included several collimation conditions defining the beam
size: 2x2, 3x3,4x4, 6x6, 8x8, 10x10, 15x15, 20x20, 30x30 and 40x40 cm2. Different energies
were considered: 6, 10 and 15 MeV. The comparison was based on the PDD and dose profiles
at different depths in water tank under reference conditions.
After this process the phase spaces were considered a valid model of the installed TrueBeam
unit and used thereafter in all the simulations during this work.
Table 3.1: Summary of the characteristics of the initial electron sources, as described in the header files
of Varian phase space file (PHSP)
6FFF 10FFF 15X
Stored position Z 26,7 cm 26,7 cm 26,7 cm
Number of original histories 6, 5× 107 3, 24× 108 6× 108
Mean energy 5,9 MeV 10,2 MeV 13,5 MeV
Energy sigma 0,051 MeV 0,2 MeV 0,27 MeV
Energy FWHM 0,12 MeV 0,2 MeV 0,27 MeV
sigma X 0,6645 mm 0,8118 mm 0,6415 mm
sigma Y 0,7274 mm 0,8001 mm 0,5768 mm
Beam divergence 1 mrad 1mrad 1 mrad
The Collimator
As the collimator was extensively used during the work in order to simulate their modulation
effect on the radiation beam, a test was made in order to give an answer to whether the MLC
model furnished by PRIMO is acceptable and a user can be confident on it. For the validation
of the modelled multileaf collimator (MLC) an irregular shape conformed by the MLC was sim-
ulated, Figure 3.1. The same leaves configuration was irradiated in a phantom constituted by a
set of slabs of RW3, constituting a box of 15 cm of height. The measure was taken making use
of a Gaphcromic film placed at 5cm depth from the surface of the top slab, 100cm SAD set-up.
This procedure was repeated for the 6FFF and 10FFF energies.
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Fig. 3.1. Leaves configuration used in MLC validation.
3.2.2 Simulation of dynamics procedures
With the machine model validation complete the following step was to validate the sampling
algorithm. As PRIMO does not have intrinsically the functionality of IMR or VMAT simulation,
a suitable algorithm had to be developed in order to drive the software to simulate a dynamic
procedure. In this context an in house graphical application was developed to assist the stan-
dardized configuration of PRIMO.This application is referred as APP. Several modules had to
be included in the application, each one dealing with a specific purpose, Figure 3.2. Firstly, the
module to allow PRIMO to interface with the TPS was developed to allow importing dynamic
information, relative to component motion during the procedure. This step was conducted mak-
ing use of either the DICOM plan file or the mlc modulation files, both downloadable by the
TPS. Since both the DICOM and the mlc files are structured in a sequence of discrete control
points which contains the data sampled from the treatment delivery planned, the data relative
to each control point (e.g., the beam modifiers positions and the correspondent MUs delivered)
are extracted from the TPS files and processed, followed by the generation of the fields to use
in the simulation through random sampling and subsequent interpolation. This fields are then
written to a PRIMO configuration file for posterior simulation execution.
Fig. 3.2. Block diagram of the workflow.
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Sampling algorithm
From what discussed in 2.6, in this work, a stochastic method was developed to model the dy-
namic motion of the beam modifiers with the Monte Carlo simulation of the IM fields. The sim-
ulation of the elements motion was accomplished by the Probability-Position-Sampling (PPS)
method, in which MUindex array of the CPs to simulate was randomized. As a consequence,
the number of particles being simulated for each sampled segment was considered propor-
tional to the MUs or dose delivered for that segment or position. In order to deal with the time
dependence on the four-dimensional dose calculation a transformation of the factor of time into
the MUs or dose being delivered was done, because of their direct correlation. Consequently,
the length of time can be more naturally folded into MC simulation by batching the number of
histories or dose according to the MUs. From the number of segments for the IM fields, beam
modifiers position in the segment and the MU index of each segment the sampling algorithm
generates random IM fields that try to resemble the movement. From the input data, DICOM
or mlc files, the dynamic trajectory of all the components are calculated. The PRIMO, as all
the software, works by finite states configurations and the motion is modelled by considering a
number of static configurations. The position of all the components are interpolated from the
trajectory at specific time fraction as defined by the randomly generated MU. The MU index is
the incremental or cumulative MUs that will be delivered up to the completion of the current
segment and its delivery will depend on the operation mode, i.e., step-and-shoot or sweeping-
leaf. In the context of present work only the last was considered however the algorithm works
similarly in the former case. The MU index of the IM field can be seen as the Cumulative Prob-
ability Distribution Function (CPDF) of each segment or beam modifier position. Therefore the
positions can be randomized from the MUs that in turn have a direct relation with dose delivered
by segment [2]. Somehow, the positions are sampled from the predetermined trajectories spec-
ified in the mlc or DICOM file, depending of the origin, with the probability position governed by
the CPDF. The sampling algorithm works as following:
1. A set of n-1random numbers, where n is the number of final IM sub-fields desired are
generated.
2. 0.0 at the begin and 1.0 at the end are added to the random number sequence. This n+1
random numbers represent the extremes of the n wanted IM random fields in terms of
MUindex.
3. The system configuration is interpolated at the value of MUindex correspondent to the
center of the interval.
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4. A weight proportional to the MU fraction of the correspondent interval is attributed to each
of the sampled IM field. Finally, the sum of the intervals will be 1 and the final dose can
be computed as the weighted sum of the doses of the IM sub-fields simulated.
As a side note, some brief tests were conducted to assess the error introduced by interpo-
lating at the center of the interval, or at the mos probable position inside the interval, especially
in the case of the existence of a great modulation inside the interval. The observed differences
for the case of a large number of fields,i.e, small interval widths, were negligible and don’t justify
the cost time consuming operation to iterate the most probable position inside the interval by
randomization.
Dynamic MLC with Gantry fixed
A standard dynamic MLC procedure, known as the ”Gap” was planned using the TPS and
transferred to the LINAC for irradiation. The mlc file of this plan was extracted from the TPS
for elaboration and simulation of this configuration. This mlc file, with 13 control points was
imported into the APP and a sampling of 180 randomly interpolated fields was generated.
The resulted sampling was exported to the corresponding ”.ppj” project file created for this
simulation. The simulation was taken in a 2 steps way, first, the validated phase space at s1
was used as the radiation source for the s2 stage. The simulation of the s2 was carried out
followed by the s3 stage of dose deposition calculation in a multislab RW3 solid water phantom,
with the surface placed at 95 cm from the LINAC source position. The same procedure was
delivered at the LINAC stage and the measurement performed with a gafchromic film at a depth
of 5 cm from the surface of the top slab.
Dynamic MLC and Gantry
As in the last case, a 6FFF pre-planned test VMAT, with 16 control points was imported from
a DICOM format into the APP, sampled and exported to PRIMO for simulation. Again the
simulation was executed following the steps described but in this case the phantom used was
an OCTAVIUS4D R©. A CT scan of the phantom was imported in PRIMO and treated as a
homogeneous RW3 material. The same plan in the same set-up was irradiated with a film
at the referred position. As the available CT of the phantom did not have the slabs used for
sandwich the film, in the middle of the phantom, this was processed with Matlab, where the HU
values in that region were replaced by the HU value corresponding to RW3.
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TB machine movement log simulation
In order to simulate the real movement of the beam modifiers first of all a module that could read
the binary file was coded, implementing the header specifications supplied by Varian, where
the TrueBeam (TB) stores the information. Later, the usual steps of sampling the maximum
180 randomly interpolated fields, PRIMO export and PRIMO simulation and doses integration
operations were carried on.
Clinical case study
Without a priori constraints, an available VMAT treatment plan made for TrueBeam with energy
6 MeV FFF was chosen to test the whole workflow as enumerated below and with a graphical
view in Appendix A.1. The original treatment consisted of 2 dynamic arcs. Arc 1 with CC gantry
rotation and arc 2 with CW rotation. Each arc was originally defined with 98 control points.
1. Export the selected plan from the TPS in DICOM format.
2. Import the DICOM file in the VMAT APP.
3. Select arc 1 and choose the number of random fields wanted to sample the dynamic
treatment. The choice was the 180 maximum number of fields allowed by PRIMO in
order to not under-sample the dynamic trajectory of the system.
4. Export the sampled fields to the PRIMO configuration file. This process generates a joint
file with the relative weight of each sampled field to use in later dose integration.
5. Repeat steps 3 and 4 for the remaining arcs. In this case Arc number 2.
6. Open PRIMO with the first configuration file.
7. Import CT and set the isocenter.
8. Simulate s2 and Simulate s3.
9. Close PRIMO and move the output calculated dose files to a backup folder.
10. Replace configuration file with the one of the Arc 2.
11. Reopen PRIMO and repeat step 8.
12. With VMAT APP integrate calculated dose files for Arc 1 using the corresponding weight
file.
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13. Repeat the integration for the calculated dose files of Arc 2.
14. Integrate the 2 output files from 12 and 13, using weights equal to 1 for each, in teh case
that the total monitor units are equally divided between the two arcs.
15. Generate DICOM for all slices or only for the depth of interest from the integrated dose
file.
16. Compare this output with the dose calculated by the TPS. This was done using Verisoft
and the RD DICOM file exported from the TPS.
MC calculated doses evaluation
With exception of the Clinal case(s), all the other simulations were compared with the real mea-
surements performed with the TB. Each Gafchromic film irradiated was scanned and processed
with DoseLab R©from PTW where the corresponding calibration curve was applied in order to
obtain the dose distributions. On the other hand from the PRIMO simulations the accessible
result was not a unique distribution but several with the dose deposited by each of the 180 fields
simulated. To overcome this a module was coded that imported this files, applied the respective
weight and produced a unique dose file. From the resulting integrating dose distribution a slice
corresponding to the desired depth was extracted the and exported to DICOM.
The exported DICOM and a DICOM generated from the tif Gafchromic digitalized dose distribu-
tion from DoseLab, were imported into the Verisoft PTW software for a gamma 2D evaluation.
All the dose distributions originated from the simulation, film measurement and TPS calculation
were compared with each other in Verisoft.
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4. Results and Discussion
The results from the several steps taken in the implementation phase as described along the
chapter 3, are exposed in this chapter. Firstly, the results for the simulation of the TrueBeam
linac model for the desired energies, i.e. 6MV and 10MV operating in Flatness Filter Free
(FFF), and the respective validation through the gamma comparisons with the respective mea-
surements of reference from the linac commissioning work are shown. Later, a subsection is
dedicated to the results of the simulation used to validate the multileaf collimator (MLC) HD120
mounted in the TrueBeam linac is equipment.
In addition, the results of the dynamic simulations, of algorithm sampling validation to the the
workflow application to dynamic treatments, including a TrueBeam ”TrajectoryMachineLog” and
a real clinical case are shown. Finally the GUI Matlab application built is described and ex-
plained.
4.1 Validation
4.1.1 Beam
Phase Spaces
The use of PRIMO for the beam simulations showed to be able, on one hand to generate
models of the Varian Trubeam Linac machine and to the other, to validate the PHSP files
available from Varian repository. Both ways are viable options to get a functional model of the
LINAC, although the latter option should be preferred as it is less time consuming, since the
first option involved to generate a PHSP with PRIMO using the FakeBeam model, which results
in longer simulation times and very large files which will induce longer times in the subsequent
s2 stage simulations.
Results of the analysis within PRIMO of the Phase Space used for the 6MV FFF that re-
sulted from the Varian PHSP import are shown in Figure 4.1 and 4.2. Energy spectra and
angular distribution of particles crossing the PHSP are shown for each kind of particles PRIMO
is able to deal with, photons, electrons and positrons.
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Fig. 4.1. Varian Phase Space as a valid model of the linac head and as the source of particle for the
subsequent s2 stage of the simulation through jaws and MLC.
Fig. 4.2. PRIMO analysis of the Phase Space used as source for the 6MV Flatness Filter Free (FFF)
beam.
The calculated PDDs and Lateral Profiles
The normalized curves obtained from the simulation of the different field sizes, different
depths and energies, used for the comparison with the reference values that resulted from the
commissioning of the TrueBeam are shown. Square fields are considered, from 2x2 cm2 to
40x40 cm2 and the curves plotted for the lateral profiles were extracted from PRIMO, at each
desired depth, with the tool for dose inspection, accessible after the s3 stage calculation.
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The 6MV-FFF The Percentage Depth Dose profiles
Fig. 4.3. 6MV FFF - normalized PDDs to each PDD maximum dose depth
In Figure 4.3 the PDD are shown, each one normalized to its specific maximum. As a
general note, for this energy a build up region of approximately 14 mm is calculated, in line with
measurements, where the maximum dose can be found. For greater depths is observed that
to a larger field corresponds a higher absolute dose with depth.
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The 6MVFFF lateral profiles at different depths obtained with the various open field
sizes.
(a) 6MV FFF - normalized lateral profiles at depth
14 mm
(b) 6MV FFF - normalized lateral profiles at depth
50 mm
(c) 6MV FFF - normalized lateral profiles at depth
100 mm
(d) 6MV FFF - normalized lateral profiles at depth
200 mm
(e) 6MV FFF - normalized lateral profiles at depth
300 mm
Fig. 4.4. 6 MV FFF lateral profiles
Figure 4.4 shows the lateral dose profiles when open fields with different size are used.
The data are normalized to the maximum value of the PDD, in order to keep the absolute
normalization between different fields. The data show that the larger the field the higher the
absolute value. This is due to scattering effects, which depend of the field size as the lateral
contribution increases while increasing the field size.
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The 6 MV FFF lateral profiles for different field sizes at the various commissioned
depths.
(a) 6MV FFF - normalized lateral profiles for 20X20
(mmxmm) field size
(b) 6MV FFF - normalized lateral profiles for 30X30
(mmxmm) field size
(c) 6MV FFF - normalized lateral profiles for 40X40
(mmxmm) field size
(d) 6MV FFF - normalized lateral profiles for 60X60
(mmxmm) field size
(e) 6MV FFF - normalized lateral profiles for 80X80
(mmxmm) field size
(f) 6MV FFF - normalized lateral profiles for 100X100
(mmxmm) field size
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(g) 6MV FFF - normalized lateral profiles for 150X150
(mmxmm) field size
(h) 6MV FFF - normalized lateral profiles for 200X200
(mmxmm) field size
(i) 6MV FFF - normalized lateral profiles for 300X300
(mmxmm) field size
(j) 6MV FFF - normalized lateral profiles for 400X400
(mmxmm) field size
Fig. 4.5. 6 MV FFF lateral profiles
Figure 4.5 shows the lateral profile at different depths when a fixed beam size is considered.
The absolute normalization is kept, that is the data are normalized with respect to the maximum
dose value. While increasing the depth of the profile at a fixed beam size two features can be
observed. Firstly, the beam enlarges with depth. The effect is given by the aperture of the beam
and by scattering effects. Secondly, the maximum normalized value depends on the depth and
decrease for deeper profiles.
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The 10MV-FFF Percentage Depth Dose Profiles
Fig. 4.6. 10MV FFF - normalized PDDs to each PDD maximum dose depth
The 10MVFFF lateral profiles at different depths obtained with the various open field
sizes.
(a) 10MV FFF - normalized lateral profiles at depth 23mm (b) 10MV FFF - normalized lateral profiles at depth 50mm
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(c) 10MV FFF - normalized lateral profiles at depth
100mm
(d) 10MV FFF - normalized lateral profiles at depth
200mm
(e) 10MV FFF - normalized lateral profiles at depth
300mm
Fig. 4.7. 10 MV FFF Normalized lateral profiles
10 MV FFF lateral profiles obtained with the different field sizes used.
(a) 10MV FFF - normalized lateral profiles for 20X20
(mmxmm) field size
(b) 10MV FFF - normalized lateral profiles for 30X30
(mmxmm) field size
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(c) 10MV FFF - normalized lateral profiles for 40X40
(mmxmm) field size
(d) 10MV FFF - normalized lateral profiles for 60X60
(mmxmm) field size
(e) 10MV FFF - normalized lateral profiles for 80X80
(mmxmm) field size
(f) 10MV FFF - normalized lateral profiles for 100X100
(mmxmm)
(g) 10MV FFF - normalized lateral profiles for 150X150
(mmxmm)
(h) 10MV FFF - normalized lateral profiles for 200X200
(mmxmm)
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(i) 10MV FFF - normalized lateral profiles for 300X300
(mmxmm)
(j) 10MV FFF - normalized lateral profiles for 400X400
(mmxmm)
Fig. 4.8. 10 MV FFF lateral profiles obtained with the different field sizes used.
The 15X MV- working in FF mode. Percentage Depth Dose profiles
Fig. 4.9. 15X MV, working in FF, normalized PDDs to each PDD maximum dose depth
Figure 4.9 show the PDDs for the 15MV energy and working in Flatness Filter (FF). The
build up region is of approximately 28mm.
FCUP 51
Clinical implementation of Monte Carlo simulations of a TrueBeam unit
PRIMO Gamma index evaluation results
The Figures 4.10, 4.11, 4.12 and 4.13 illustrates the PRIMO functionality that allows to
perform the gamma analysis of the MC calculations with respect to the measured reference
values. In Figure 4.10 the comparisons between experimental and simulated PDD are shown,
while Figure 4.11 reports the same analysis for lateral profiles at the depth of maximum central
axis (CAX) dose for each energy and for the typical 100X100 mm2 field size. The data refers to
6 MV radiation beam.
Fig. 4.10. Gamma PDD comparison for the case of a 100X100 mm field size and energy 6MV Flatness
Filter Free (FFF)
Fig. 4.11. Gamma Lateral profile comparison for the case of a 100X100 mm field size and energy 6MV
Flatness Filter Free (FFF) at 14mm depth
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Fig. 4.12. Gamma PDD comparison for the case of a 100X100 mm field size and energy 10 Flatness
Filter (FF)
Fig. 4.13. Gamma Lateral profile comparison for the case of a 100X100 mm field size and energy 10MV
Flatness Filter Free (FFF) at 23mm depth
Figures 4.12 and 4.13 show the Gamma analysis for the 10MV beam. As a general feature,
it is observed that the gamma function assumes higher value in coincidence with steep gradient
region, that is the build-up region of the PDD and the edge regions of the dose profiles. Even
if some gamma points are higher than one, in all the cases the gamma pass/fail criteria is
respected.
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The Tables 4.1, 4.2 and 4.3 numerically resume the results from the gamma comparison,
with a criteria of 2%-2mm, for the PDDs and lateral profiles of all the fields sizes calculated and
measured for the simulated energies of 6MV FFF, 10MV FFF and 15MV, respectively.
Table 4.1: Gamma index results for energy 6MV Flatness Filter Free (FFF) - values in (%) percentage of
passing points
Field Size (mmxmm) PDD
Depth (mm)
14 50 100 200 300
020 x 020 99.06 97.33 96.75 96.30 97.73 99.48
030 x 030 99.69 97.50 97.56 97.67 98.40 98.53
040 x 040 99.69 96.47 96.59 98.37 99.00 99.08
060 x 060 99.69 100.00 97.96 99.03 99.11 99.59
080 x 080 99.06 97.14 100.00 99.12 100.00 100.00
100 x 100 100.00 99.13 100.00 98.40 99.63 100.00
150 x 150 100.00 97.14 96.55 98.68 99.10 98.61
200 x 200 100.00 96.39 97.67 97.78 97.19 97.75
300 x 300 100.00 99.54 100.00 100.00 100.00 100.00
400 x 400 100.00 100.00 100.00 100.00 100.00 100.00
Table 4.2: Gamma index results for energy 10MV Flatness Filter Free (FFF) - values in (%) percentage
of passing points
Field Size (mmxmm) PDD
Depth (mm)
23 50 100 200 300
020 x 020 99.06 97.33 98.70 98.77 98.30 100.00
030 x 030 99.69 98.13 98.78 98.84 98.40 99.51
040 x 040 99.69 97.65 99.43 98.91 100.00 99.54
060 x 060 99.69 97.92 100.00 99.51 99.55 100.00
080 x 080 99.38 99.06 100.00 99.12 100.00 100.00
100 x 100 100.00 100.00 100.00 100.00 100.00 100.00
150 x 150 100.00 100.00 100.00 100.00 100.00 100.00
200 x 200 100.00 100.00 100.00 100.00 100.00 100.00
300 x 300 100.00 100.00 100.00 100.00 100.00 100.00
400 x 400 100.00 100.00 100.00 100.00 100.00 100.00
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Table 4.3: Gamma index results for energy 15MV - values in (%) percentage of passing points
Field Size (mmxmm) PDD
Depth (mm)
28 50 100 200 300
020 x 020 99.38 98.68 98.70 100.00 98.86 97.62
030 x 030 99.38 98.77 97.56 98.84 99.47 99.51
040 x 040 100.00 98.26 98.86 98.37 99.50 99.54
060 x 060 100.00 97.40 98.98 99.03 99.11 99.59
080 x 080 100.00 99.06 99.54 99.56 99.19 99.63
100 x 100 99.69 100.00 98.74 99.20 100.00 100.00
150 x 150 99.38 100.00 100.00 99.67 100.00 100.00
200 x 200 99.69 100.00 100.00 100.00 100.00 100.00
300 x 300 99.38 100.00 100.00 100.00 100.00 NA
400 x 400 99.69 100.00 100.00 100.00 100.00 99.50
As can bee seen from the results presented in the tables, in all the cases reported more
than 95% of gamma points passed the acceptance criteria, 2%-2mm as the Gamma parame-
ters. In general, small size fields show a lower number of gamma points accepted on the beam
profiles, while 10MV and 15MV show better agreement than 6MV.
Hereafter, the validated PHSP of the PRIMO linac model can be confidently used for all the
MC in future simulations related to this machine and these validated energies.
4.1.2 Collimator validation
The MLC model within PRIMO was validated with respect to measurements making use of the
2D Gamma analysis, 2% - 2 mm, and 95% as the minimum fraction of gamma points accepted
as pass/fail criteria. This result allowed the use of the MLC model in the MC simulations of in-
tensity modulated fields. The gamma 2D analysis on the 6MV case showed 94.9% of Gamma
points accepted using the usual 2% - 2mm gamma parameters, while increasing the parame-
ters to 3% - 3mm, the Gamma accepted points increased to 98.7%. The correspondent values
for the TPS calculation are 89.8% and 93.9%, which reveal a worse agreement with the mea-
surement than the MC.
Considering the same analysis on the 10MV simulation case, were obtained 98.0% and 99.3%
accepted points with 2% - 2mm and 3% - 3mm respectively, while the TPS showed 93.7% and
96.9% Gamma points lower than 1, confirming the worse calculation capability of TPS in this
particular field shape condition.
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PTW Verisoft was here used to calculate 2D Gamma distributions, as PRIMO does not pro-
vide yet such advanced calculation tools. A data manipulation was required in order to import
PRIMO output into Verisoft as the PRIMO output are written in specific format. The core rou-
tines for this task were inherited from previous works done at IPO and incorporated in the APP,
with the introduction of the automatic detection of the type of PRIMO dose file, i.e. water tank
phantom or CT, feature.
(a) Gaphchromic measure
(b) Monte Carlo (MC) calcula-
tion
(c) MC Gamma 2% 2mm com-
parison
(d) MC Gamma 3% 3mm com-
parison
(e) treatment planning system
(TPS) calculation
(f) TPS Gamma 2% 2mm com-
parison
(g) TPS Gamma 3% 3mm com-
parison
Fig. 4.14. Results for the MLC validation with 6 MV FFF. Gamma comparison between MC calculation
and Measurement and between TPS and measurement, respectively, obtained with Verisoft PTW.
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(a) Gaphchromic measure
(b) Monte Carlo (MC) calculation (c) MC Gamma 2% 2mm compari-
son
(d) MC Gamma 3% 3mm compari-
son
(e) treatment planning system
(TPS) calculation
(f) TPS Gamma 2% 2mm compari-
son
(g) TPS Gamma 3% 3mm compari-
son
Fig. 4.15. Results for the MLC validation with 10 MV FFF. Gamma comparison between MC calculation
and Measurement and between TPS and measurement, respectively, obtained with Verisoft PTW.
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4.1.3 Sampling algorithm
The continuous intensity modulation with time was assessed through the implementation of an
algorithm that executes a probabilistic sampling of the position of the different beam modifiers,
based on the cumulative MUs, following the Position Probability Sampling (PPS) approach.
The first test performed to test the algorithm consisted of simulating the MLC movement and
keeping the Gantry fixed as shown in Figure 4.16. The requirement for the planned MLC
movements was to create a homogeneous dose area in a definite treatment area. Agreement
between the MC simulation and the Gaphchromic is confirmed by 94.0% with 2% - 2 mm and
of 99,2% with 3% - 3mm Gamma points lower than 1. As for the case of the TPS, for the same
criteria, the results shown an agreement with the Gaphchromic measured of 94,7% and 99,6%
respectively. The same kind of tests, keeping the same criteria for the Gamma comparisons,
included the movement of the Gantry, as shown in Figure 4.17. An agreement of 92,2% for
the 2% - 2mm and 97,1% for the 3% - 3mm between the MC simulation and the Gaphchromic,
revealed reliability in the sampling method. The same analysis between the TPS calculation
and the Gaphchromic measurement showed 96,1% of 2% - 2mm accepted Gamma points and
99,8% accepted 3% - 3mm Gamma points.
As for the test of the reverse engineering process for reconstruction of the dose distribution
from the snapshots stored in the TrajectoryLog, for the IMRT like case, i.e. gantry fixed and MLC
dynamic, the agreement achieved between MC simulation and Gaphchromic was of 90.4% with
2% - 2mm and of 97.6% with 3% - 3mm Gamma points < 1, respectively. For the VMAT like
case, i.e., both gantry and MLC allowed to move dynamically, the agreement achieved between
the MC simulation and the Ghaphcromic measurement using the Octavius phantom was of
82.6% Gamma points < 1 with criteria 2% - 2mm and of 92.8% of Gamma < 1 with criteria 3%
- 3mm. These results suggests that the introduction of the degree of freedom corresponding
to the gantry movement and consequently of higher modulation fluence delivered may need a
greater number of fields to represent it with the desired level of accuracy.
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IMRT - Dynamic MLC with fixed Gantry
(a) Gaphchromic measure
(b) Monte Carlo (MC) calculation (c) MC Gamma 2% 2mm compari-
son
(d) MC Gamma 3% 3mm compari-
son
(e) treatment planning system
(TPS) calculation
(f) TPS Gamma 2% 2mm compari-
son
(g) TPS Gamma 3% 3mm compari-
son
Fig. 4.16. Results for the IMRT sampling algorithm validation with 6 MV FFF. Gamma comparison
between MC calculation and Measurement and between TPS and measurement, respectively, obtained
with Verisoft PTW.
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VMAT - Dynamic MLC with moving Gantry
(a) Gaphchromic measure
(b) Monte Carlo (MC) calculation
(c) MC Gamma 2% 2mm compari-
son
(d) MC Gamma 3% 3mm compari-
son
(e) treatment planning system
(TPS) calculation (f) TPS Gamma 2% 2mm compari-
son
(g) TPS Gamma 3% 3mm compari-
son
Fig. 4.17. Results for the VMAT sampling algorithm validation with 6 MV FFF. Gamma comparison
between MC calculation and Measurement and between TPS and measurement, respectively, obtained
with Verisoft PTW.
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IMRT - Trajectory Log simulation
(a) Gaphcromic measure
(b) Monte Carlo (MC) calculation (c) MC Gamma 2% 2mm compari-
son
(d) MC Gamma 3% 3mm compari-
son
Fig. 4.18. Results for the IMRT trajectory log sampling algorithm validation with 6 MV FFF. Gamma
comparison between MC calculation of the trajectory log and Measurement, obtained with Verisoft PTW.
FCUP 61
Clinical implementation of Monte Carlo simulations of a TrueBeam unit
VMAT - Trajectory Log Simulation
(a) Gaphchromic measure
(b) Monte Carlo (MC) calculation (c) MC Gamma 2% 2mm compari-
son
(d) MC Gamma 3% 3mm compari-
son
Fig. 4.19. Results for the VMAT trajectory log sampling algorithm validation with 6 MV FFF. Gamma
comparison between MC calculation of the trajectory log and Measurement, obtained with Verisoft PTW.
All these results gave support to the viability of using PRIMO to simulate the dynamic treat-
ments as was the premise of the start of this work.
Although the encouraging results the necessary operations to implement the whole strategy
were not simple and very dispersed, so a workflow was designed to simplify the introduction
of PRIMO MC simulations for dynamic treatments. To implement this workflow an application
was developed exposing a graphical interface that encapsulated the several tasks to perform,
including the data processing and data preparation needed for the simulations and for the cal-
culation evaluations.
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4.2 Matlab Application
Although the PRIMO system offers a graphical user interface that allows to easily and quickly
overcome several tedious tasks common to any MC simulation, it does not include by default
the possibility of simulate dynamic fields like IMRT or VMAT treatments. PRIMO allows to
simulate up to a maximum number of 180 static fields, but to set up each one of them by
hand can be a cumbersome task. Besides this, although the final resulting dose distribution
calculated by PRIMO can be visually accessed, this final result cannot be extracted to further
comparison with the reference distribution in external software. What is stored by PRIMO is
the individual result for each one of the simulated fields. In order to build a work-flow capable
of integrating the use of MC to simulate the dynamic treatments, and following the PRIMO
approach as a user-friendly software, one of the principal objectives of this work was to build
an application that would expose an easy to use Graphical User Interface (GUI) and put in the
background and automatize the routine tasks. The principal routine tasks identified were: the
reading of the TPS Dicom or ”.mlc” files, the Machine log files, the sampling of the fields to
simulate, the construction of the PRIMO ”.ppj” configuration file, the reading and integration of
the dose files generated by PRIMO and the generation of the Dicom files that could be used
to compare with the reference distribution in external 3rd party software, e.g. VeriSoft PTW,
Friburg. In a first approach several functions already developed at IPO in previous works were
used and a deep work of optimization was done, trying to vectorize where possible to reduce
the matrix manipulation times. Whenever possible the redundant tasks spread by different
functions were condensed, mainly through the introduction of parsing functionality and regular
expressions. A Graphical User Interface necessary to the present work was designed and
constructed. Finally a work of code encapsulation into classes was done in order to get a
more modular, maintainable and reusable code. The resulting application is composed by the
following principal components (View Classes diagram A.2):
• VMAT APP, is the entry point for the application and is responsible for managing the ac-
cess to the principal components of the application. From the Menu the different modules
can be called as needed, Figure 4.20.
Fig. 4.20. APP Main Menu
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• TPSFile, this module manages the operations related with the files originated from the
treatment planning system (TPS) in format DICOM (dcm extension) or mlc.
(a) Selection of the beam to sample. Although all present
beams in the DICOM are shown, only the dynamic ones
are processed, in this case Field 1 and Field 2.
(b) Choosing the number of fields to sample. Minimum 3
and maximum 180.
(c) Available options after successful sampling
Fig. 4.21. APP TPSFile - Beam selection, sampling and results options layouts.
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(a) Inspection of the result of the Gantry movement sam-
pling. Magnifier pretends to show the difference between
original (blue) and sampled (orange) movements
(b) inspection of the result of the sampling of the Jaws
movement.
(c) example of a view of the result of sampling of the MLC
(Leaf 18 Bank A)
(d) example of a view of the result of sampling of the MLC
(Leaf 24 Bank B)
Fig. 4.22. APP TPSFile - Inspection of the results for the sampled Gantry, Jaws and MLC leafs move-
ment.
Figure 4.22 exemplifies the functionality implemented to help visualize the end result of
the random sampling of movement process, showing the new positions as a function of
the Monitor Units. For this particular case tested, (a) refers to the sampling of the gantry
angle and the magnifier was used to show a that there are actually two different curves,
the original (blue) and the sampled one (orange); (b) shows the resulting X and Y jaws
sampled positions; (c) and (d) refers to the MLC leafs sampling, in concrete to the leaf 18
of the Bank A and to the leaf 24 of the Bank B, respectively. The Blue line represents the
original motion and the red circles the sampled points. The slider at the bottom left corner
allows to navigate through the leafs of the respective Bank.
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(a) Oleaf and Sleaf allows a preview, for inspection, of the
original and sampled leafs movement.
(b) Functionality for comparison between original and sam-
pled estimated Intensity Maps, with tolerance of 5% differ-
ence between them point by point (1mm).
Fig. 4.23. Implemented functionality for inspection of segments of leaf movement and expected fluence
maps.
• Sampling this module implements the random sampling algorithm of the dynamic treat-
ment.
• PRIMOFile In this class the read and write mechanisms related with the PRIMO project
configuration files, with extension ”.ppj” are implemented.
• BINFile this is the equivalent module to TPSFile but for the case of the binary trajectory
log files originated by the TrueBeam linac, with extension ”.bin”.
• DosePRIMO this module operates the reading of a dose file with PRIMO format and
extension ”.f#”, where # is an integer number. This class builds the dose matrix from the
files read and allows exporting the slices of interest in dicom format, to use, for instance
in further comparisons with the reference distributions with a third program like Verisoft
PTW.
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(a) Entry point for the DosePrimo Module after dose file is
choosen.
(b) The slices can be selected by index or by position.
(c) The slices can be selected by index or by position. (d) Multi slices selection is possible.
(e) Given the Prefix the dicom files are generated through the
Dicom Menu.
Fig. 4.24. APP DosePRIMO Module functions
• DoseIntegrator reads a set of PRIMO dose files and allows to attribute weights to each
one of them and produces a single file with the weighted calculated doses. The weights
can be loaded from a file, e.g. the file generated by the PRIMOFile:: exportPRIMOFile
APP module, or from the clipboard through the copy&past mechanism that this class
implements.
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(a) Dose files to integrate and weight from file or clipboard are loaded.
(b) The integrate button starts the integrating process that results in a one file with name choosen.
Fig. 4.25. APP DoseIntegrator Module functions
• FluenceTest module responsible for the comparison between the expected original and
sampled Intensity Maps, and is used as an accessory tool for the number of fields opti-
mization, view Figure 4.23(b).
This tool was also used to study the relationship between the number of fields and the
expected result from the sampled fields.
The algorithm that performs the expected fluences comparison and number of fields op-
timization works as follows:
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1. It sets a spatial grid with a size that covers all the incident fluence and with a resolu-
tion of 1 mm x 1 mm. In case of the fixed gantry is set to 200 mm x 200 mm. In the
case of a moving gantry the grid have size (max angle - min angle) mm x 200 mm.
2. For each control point the respective MUs are accumulated in the respective original
or sampled grid and in the corresponding position with the referred 1 mm X 1mm
resolution.
3. The comparison between the original and sampled fluences is made by subtract-
ing one from the other and dividing the absolute value by the original value. This
operation is performed pixel by pixel, where the pixel dimension is defined by the
resolution that is chosen by the user.
4. The evaluation takes in consideration the user criteria, i.e., the space resolution and
fluence difference tolerance. In the end overall evaluation is given as the percentage
of points inside the criteria over the total number of points evaluated.
5. The optimizer uses this algorithm as an inverse optimization to iteratively sample the
original control points until it finds a configuration that shows a comparison with a
percentage number of passing points greater or equal to the objective value. The
convergence is obtained when the agreement between the expected fluence and the
sampled Control points integrated fluence shows the objectives for the percentage
points and tolerance defined by the user. While the convergence is not obtained, a
new sampling operation is iterated increasing the number of sampling projection by
1.
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The relationship between the number of sampled fields and the resolution obtained.
Are 180 fields enough?
Using the FluenceTest module some tests were conducted to understand the influence of
the number of sampled fields. First test conducted consisted in generating 100 runs with in-
dependent configurations from 3 to 180 fields and assessing the resulted predicted accuracy,
Figure 4.26(a). A second test consisted in 100 runs with the objective of finding the minimum
number of fields needed to achieve a pre-defined objective, Figure 4.26(b). In this case within
each run, starting at 3 fields, a new independent configuration with one more field was added
until the pre-defined objective was achieved.
With the validity domain of the modulation used, for the first test, can be noted that the expected
accuracy increases as the number of fields used increases but at approximately 100 fields can
be found the elbow where it enters at a plateau and asymptotically approaches the objective.
As for the second test conducted the results show that for the degree of agreement pre-defined
of 97,5% of the pixels with maximum difference of 5% the number of fields required always
exceeded the 180 maximum available at PRIMO, although the great proportion of times it was
not far, at around 190 fields needed.
(a) Relationship between the number of fields sampled and
the best match expected
(b) Number of fields needed to achieve the requested point-
to-point matching objective of 97.5% with a 5% difference in
tolerance.
Fig. 4.26. Tests made with the FluenceTest module with the objective of assessing the number of
sampled fields influence.
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4.3 Clinical Case
The real VMAT case tested shown an agreement between the PRIMO MC calculation and the
TPS calculation of 98,4% with criteria 2% / 2 mm for the Arc 1. As for the Arc 2 resulted 95,8%
for the same criteria. When considering both arcs the integral treatment, gave the result of
97,2% points with gamma < 1 with the same 2% - 2mm criteria. Adding to the possibility of
the simulation and evaluation of a TPS calculation for a dynamic treatment, the workflow and
application also contemplate the possibility of simulation of the Trubeam trajectory logs which
allows to assess the real deposited dose distribution and compare with the expected one.
Arc 1 - Calculation results
(a) Arc 1 TPS calculation (b) Arc 1 MC Calculation
(c) Gamma evaluation
Fig. 4.27. Arc 1 - Gamma evaluation 2% 2mm between TPS calculation and MC simulation.
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Arc 2 - Calculation results
(a) Arc 2 TPS calculation (b) Arc 2 MC Calculation
(c) Gamma evaluation
Fig. 4.28. Arc 2 - Gamma evaluation 2% 2mm between TPS calculation and MC simulation.
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Complete Integrated treatment calculation results
(a) Total treatment TPS calculation (b) Total treatment MC Calculation
(c) Gamma evaluation
Fig. 4.29. Total treatment - Gamma evaluation 2% 2mm between TPS calculation and MC simulation.
Although the results obtained can in general be considered very good, an eternal issue that
always comes to the talk when dealing with MC arose, i.e., the time needed to perform the cal-
culations. The larger the field, the higher the number of particles to be tracked passing through
the collimator and hitting the phantom, and the longer the time needed to complete the simula-
tion. Adding to these ”natural time” to perform the simulation itself, the way PRIMO manages
data files is not optimized. The time the operating systems consumes writing and managing
large size files is still a possible obstacle for the daily use of this methodology and workflow.
The time spent in calculating is compensated, especially in conditions, where commercial al-
gorithms performances are critical, by the quality od the calculation, that in turns allows to
minimize the risks of due to algorithm calculation bias.
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5. Conclusions and Future Work
5.1 Achievements
TrueBeam Machine phase space validation allows its use for the 6FFF, 10FFF and 15MeV
Monte Carlo simulation.In addition, the validation of the MLC model and of the probabilistic
sampling algorithm developed allows simulating dynamic treatments with intensity modulation.
Finally the GUI developed and in conjunction with PRIMO allows implementing a workflow that
simplifies the application of the Monte Carlo method for the simulation of dynamic treatments
in the daily practice.
5.2 Future Work
Of course one case doesn’t make the whole history, and so, much more clinical cases should
be tested in order to check for consistency and limitations.
As the users begin to use the GUI and Workflow from their feedback a continuous improvement
process will start.
As a general statement, the number of fields should not be influenced by the number of ge-
ometries to be simulated. In other words, the total number of radiation beam particles is fixed.
The condition for this statement to be true is that the time needed by the operating system to
perform operations of read/write with large files is negligible with respect to the tracking time.
In PRIMO each field creates large text files, each one associated to a parallel process. At the
end of each beam, a post-process time is dedicated to integrate the output matrix file from each
process, and this operation can be very time consuming. Consequently, a future improvement
should be addressed to study the performance of PRIMO simulating multi-field treatments as
the case of dynamic procedures and, possibly, to minimize the number of fields to sample, once
the desired accuracy is defined. A first optimization algorithm was already implemented within
the APP but it still needs refinements.
Currently, even with the use of the APP, the workflow still implies switching between different
applications to perform some tasks. It would be a great improvement to get a higher degree of
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automation to the point of executing the whole process within the same program, ideally this
could be done within PRIMO.
Finally, in the view of the future clinical implementation of the APP, in order to assist the
clinical Medical Physicists to simulate dynamic RT procedures in the daily practice, a number
of training sessions should be dedicated to the explanation of the APP functionality and the
algorithms, working through the whole simulation configuration process.
The results of this work has been presented at the last International Conference on Monte Carlo
Techniques for Medical Applications (MCMA2017) in Naples as a poster and a collaboration is
ongoing with the development group of PRIMO. The collaboration aims to setup benchmark
conditions for the dynamic simulations, in the view of release of future version of PRIMO.
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A. Simulation Workflow
A.1 Workflow Diagram
Fig. A.1. Workflow proposed for the MC simulation of a VMAT treatment.
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A.2 VMAT APP: Classes diagram
Fig. A.2. Classes diagram for the VMAT APP
